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1 Chirality – Biological and Pharmaceutical Relevance   
 
The goal of the presented diploma work was to design, synthesize and evaluate a novel type 
of zwitterionic chiral stationary phases (zwitterionic CSPs). The development of these CSPs, 
merging the fields of organic and analytical chemistry, is targeted on chromatographic 
separation of enantiomers. When talking about chromatographic stereoselective separation 
one is inevitably faced with the concept of chirality.   
 
Chirality is a unique property of molecules that are non-superimposable with their mirror 
images. Thus, structures which are not identical but are mirror images of each other are called 
enantiomers. They have identical chemical and physical properties with one single exception - 
the antipodal rotation of plane polarized light - which is called optical activity.  Enantiomers 
are usually denoted with a prefix of R (for right handed molecules) or S (for left handed 
molecules) and are called chiral. Chiral molecules are defined as ones that are not identical 
with their mirror images. A racemic mixture is an equal mixture of two enantiomers.1 
Deviation from an equimolar ratio is called enantiomeric excess and the mixture is denoted 
non racemic. 
 
Chiral molecules are of utmost importance in living systems. Almost all of the chiral 
substances in living organisms are present in only one enantiomeric form. All but one of the 
proteinogenic amino acids are left handed (S-form) whereas the vast majority of sugars is 
right handed (R-form). (In addition to (R)- or (S)-nomenclature an old – but still widely 
spread – (L)- and (D)- nomenclature can be used to differentiate left and right handed 
molecules). As chiral amino acids are building blocks for peptides and proteins and chiral 
sugars are for polysaccharides, a chiral nature is created in all living systems.2 Chiral 
monosaccharides also build up the backbone of the DNA, which is – due to its helicale 
structure – chiral itself.  
 
Enzymes, which are almost all proteines, are catalyzing countless biochemical reactions in 
living systems. Such enzymatic reactions are amongst others based on stereospecific 
recognition between the converted molecule (substrate) and the enzyme. The stereospecifity 
of enzymes, which means that enzyme and substrate possess specific complementary 
geometric shapes, was already stated by Emil Fischer in 1894 and was later referred to as 
“Lock and Key” model.3  
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Regarding these examples makes it obvious that the absolute configuration of chiral 
molecules is of central importance. Although enantiomers have identical chemical and 
physical properties in an achiral environment, it makes a big difference which enantiomer (R 
or S) is present in a living system, since it is a chiral environment.  
One typical example is the limonene molecule found in citrus fruits (Figure 1.1). While (R)-
limonene smells of orange (S)-limonene smells of lemon.  
 
 
  
 
 
 
 
 
Figure 1.1  
 
 
A tragic consequence of the different impact of chiral substances on humans took place in the 
late 1950s and early 1960s. A drug called Contergan® comprising the pharmaceutically active 
substance thalidomide was widely used for treating morning sickness and insomnia in 
pregnant women. The years after, thousands of babys were born having deformities because 
their mothers were taking thalidomide. Later investigations showed that the (R)-form was the 
beneficial enantiomer while (S)-form was teratogenic (it has to be added that even if 
enantiomerically pure (R)-form had been used, it would have caused malformities because of 
in vivo racemisation in the special case of thalidomide.4)  
 
Another examples of chiral drugs whose enantiomers have different therapeutic properties are 
dextro- and levopropoxyphene (Figure 1.2).5 Dextropropoxyphene (known under the trade 
name Darvon®) is a painkiller while its enantiomer levopropoxyphene (Novrad®) shows 
antitussive effects. 
 
 
 
 
(R) - limonene (S) - limonene
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Figure 1.2  
 
 
L-DOPA (Figure 1.3) is a chiral non-proteinogenic amino acid and is in use for treatment of 
Parkinson`s disease whereas the other enantiomer, D-DOPA, is toxic. Consequently, only the 
L-form can be commercially used.6  
 
 
 
 
 
 
 
 
Figure 1.3  
 
 
Hundreds of other drugs could be named whose enantiomers have different effects on humans 
to back up the importance of using enantiomerically pure compounds in the pharmaceutical 
industry.  
 
Especially the Contergan tragedy made scientists – and the pharmaceutical industry - aware of 
the prime importance of the chiral character of drugs. Nowadays health and regulatory 
authorities make strict obligations to companies which are marketing drugs in racemic form. 
Detailed reports of the pharmacological and pharmacokinetic effects of the single enantiomers 
and the racemic mixtures must be given.2  
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Not only in pharmaceutical industry but also in agrochemical and pheromone chemistry the 
use of enantiomerically pure substances is desired. For example, a herbicide is used as a 
racemate where only one enantiomer is active, the other inactive represents an unnecessary 
contamination and burden for the environment.  
 
Although the importance of stereochemistry and its consequences is well known for more 
than 30 years producing single enantiomers is still a challenging task. Main advances in the 
preparation of enantiomerically pure substances – especially driven by the pharmaceutical 
industry – have been made by the fields of asymmetric synthesis and analytical and 
preparative separation techniques in the last two decades.2 Today asymmetric synthesis is seen 
as the most important area in organic chemistry.  
The term “atom economy” gained major importance, which means that producing an 
enantiopure product is bringing down costs because of avoiding the opposite, probably 
useless enantiomer. However, designing and carrying out asymmetric synthetic ways is not 
always easy – especially when it comes to industrial scale productions. And even if 
asymmetric synthesis is feasible enantioselective analytical methods are still needed in order 
to analyze and quantitate impurities.  
Therefore, enantioseparation techniques can be considered as essential (at least in analytical 
scale) in the field of chiral organic chemistry and are widely used in both analytical and 
preparative scale. 
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2 Enantioseparation 
 
Enantioseparation techniques can be classified into two categories – direct and indirect 
enantiomer separation approaches. They are distinguished in different binding interactions 
between the single enantiomer (selectand, SA) and the chiral auxiliary (selector, SO).7  
 
 
2.1 Indirect Approach  
 
Indirect separation techniques are based on the formation of covalent diastereomers from the 
single enantiomer and a chiral derivatization agent (CDA). The CDA has to be of high 
enantiomeric purity and undergoes a chemical reaction with the racemic mixture. Thus, two 
diastereomers are formed by the CDA and the respective enantiomer having different 
chemical and physical properties. The diastereomers can be separated by common achiral 
separation techniques like crystallization or liquid chromatography. After separation the 
diastereomers are split into the enantiomers and the CDAs offering the chiral compound in its 
desired enantiomeric form.  
 
 
 
 
 
 
 
   
 
 
 
 
 
Figure 2.1: Scheme for indirect separation 
 
(R)-SA 
(S)-SA
(S)-CDA
(S)-CDA-(R)-SA
(S)-CDA-(S)-SA
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The main advantage of the indirect approach can be seen in the use of conventional, well 
established achiral separation techniques. Especially crystallization is a frequently applicated 
method when carrying out large scale separations and is still widely spread in synthetic 
chemical industry. 
On the other hand, the indirect separation approach is limited in its field of application. For 
example, only enantiomers with at least one functional group available for chemical 
derivatization (for the formation of the diastereomer) can be used. Moreover, the 
transformation into diastereomers has to be carried out in conditions that avoid inversions of 
the stereogenic centers. The kinetic resolution phenomena must also be taken into 
consideration, by assuming that the reaction is driven to completion avoiding any incomplete 
reactions.7 The chiral derivatization agents (which are often isolated natural compounds or of 
synthetic origins) must be of very high enantiomeric purity.  
Indirect approaches were typically used in the beginnings of enantioseparation and are still 
widely used in industrial scale separations.8 However, the disadvantages listed above and the 
labor-intensive derivatization steps are decreasing the popularity of this method, and direct 
separation techniques for high throughput analysis are preferred nowadays.  
 
 
2.2 Direct Approach  
 
Direct enantiomer separation methodologies differ from indirect ones in formation of 
transient, noncovalent diastereomeric complexes. The single enantiomers which are getting in 
contact with the chiral selectors form a reversible SO – SA associate. These diastereomeric 
associates have different equilibrium constants resulting in different retention.  
Direct approach techniques performed with liquid chromatography (LC) are carried out either 
by use of chiral mobile phase additives (CMPA) or chiral stationary phases (CSP).  
The CMPA technique combines an achiral stationary phase and a chiral mobile phase 
additive. The racemate is injected onto a chromatographic column together with the chiral 
selector. Diastereomeric complexes are reversibly formed between the SAs and the CMPAs, 
which exhibit different physicochemical properties (e.g. association/dissociation rates, 
thermodynamic properties) and thus, make them separable on an achiral stationary phase.  
The CMPAs have to be separated from the enantiomers and recycled after separation which 
can be seen as a major disadvantage for high throughput applications.  
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An essential prerequisite is solubility of the CMPA in the mobile phase, which can be seen as 
another limiting factor as well as difficulties in reproducibility. Although application of 
CMPAs is rather inexpensive because of cheap achiral stationary phases and uncomplicated 
preparation of the chiral phase this type of direct separation approach is of only minor 
importance in present enantiomer separation.9 
The most important direct approach technique is immobilizing the chiral selector onto a 
chromatographic support material (most often silica is used) and are referred to as chiral 
stationary phases (CSP). Immobilization can be carried out in different ways like covalent 
attachment of the SO onto functionalized support materials or application of coating 
techniques. 
CSPs are operated with achiral mobile phases applying common solvent compositions as they 
are used in normal phase or reversed phase chromatography. When injecting a racemic 
mixture (under the prerequisite of a successful separation) the eluted analytes are obtained 
directly in their enantiomerically pure form. Thus, the detector signals (of the single 
enantiomers showing identical spectroscopic properties towards achiral detection systems) are 
a direct measure for enantiomeric impurities.  
Additionally, a chiral stationary phase with its permanently bonded chiral selector is more 
robust than a CMPA separation system and can typically be reused oftentimes without any 
conditioning/preparation steps. The use of achiral mobile phases produces much lower 
background signals than CMPAs containing chiral selectors and, thus, results in an increased 
sensitivity. This can be of special interest when combining a CSP with mass sensitive 
detection systems.  
Having properties like robustness in application, a broad variety of LC operation modes and 
the use of achiral bulk solvents (which can be easily evaporated off after separation) made 
CSPs an important tool for economic chromatographic separation in analytical and even 
preparative scale.7   
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2.3 Principles of Chiral Recognition  
 
Several attempts have been made in the last two decades to enlighten the processes of chiral 
recognition on a molecular level. Among numerous scientific essays one concept gained 
major importance and is currently seen as the state of art: it is known as the three-point rule 
last modified by Pirkle and states that “for chiral recognition to occur a minimum of three 
simultaneous interactions between SO and at least one of the enantiomers is required, with at 
least one of these interactions being stereochemically dependent.”10  
This means that when the chiral selectand molecules approach the chiral selector both can 
interact with the selector on basis of two interactions, but only one of the enantiomeric forms 
is able to establish a simultaneous third interaction because of its unique spatial arrangement. 
This stereochemically dependent interaction is a prerequisite for the chiral recognition 
between the selector and selectand.  
The concept of the three-point model is depicted in Figure 2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Principle of chiral recognition 
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There are single-point and multiple-point interactions. Ionic forces or hydrogen bondings, 
which are targeted on specific single atoms of the SOs and SAs, are referred to as single-point 
interactions. Dipole-dipole stacking and aromatic interactions (face-to-face and edge-to-face) 
are considered as multi-point contacts.  
Because of differences between these two types of interactions one can enlarge the definition 
of the three-point model. Therefore, it can be sufficient for chiral recognition if two 
simultaneous SO-SA interactions take place, as long one of them will be of multi-point 
quality. 
These spatial aspects of chiral recognition are closely connected with thermodynamic 
considerations. According to equation 2.1 enantioseparation is achieved when the free energy 
changes ΔG of the process of single enantiomers binding to SOs are differing. ΔGR,S 
represents the affinity of the selectand enantiomers to the chiral selectors and are related to the 
equilibrium constants KR and KS by equation 2.2. 
 
    ΔGR ≠ ΔGS                                                      [2.1] 
 
   
  ΔGR = - RT ln KR  ΔGS = - RT ln KS                                             [2.2]  
 
T = temperature in K  
R = general gas constant 
 
The retention factors kR,S are related to the equilibria constants KR,S by equation 2.3 where Φ 
is the phase ratio:  
 
   kR = KR . Φ  kS = KS . Φ               [2.3]    
 
 
Selectivity coefficient α is defined as the ratio of the retention factors of the single 
enantiomers. By convention αR,S  is calculated by dividing the retention factor of the more 
retained enantiomer by that of the less retained (kR > kS) 
 
   αR,S = kR / kS =  KR . Φ / KS . Φ         [2.4]  
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Combining equations 2.2 and 2.4 gives equation 2.5. It can be seen that α is related to the 
difference of the free energy changes between the (R) - and (S)-enantiomers (ΔΔGR,S). The 
energy differences ΔΔGR,S required for separation depend on the peak resolution capabilities 
(the efficiency) of the applied separation technique. 
 
    ΔΔGR,S = - RT ln αR,S      [2.5]  
 
 
To have a closer look at thermodynamic parameters equation 2.5 can be rewritten in the form 
of the Gibbs-Helmholtz equation 2.6:  
  
    ΔΔGR,S = ΔΔHR,S – T ΔΔSR,S               [2.6] 
 
 
    ln αR,S = - ΔΔHR,S / RT + ΔΔSR,S / R   [2.7]  
 
 
Equation 2.7 shows the relation of enantioselectivity α to enthalpic (ΔΔHR,S) and entropic 
(ΔΔSR,S) contributions as well as its dependency on the temperature. With the help of van`t 
Hoff plots (plots of ln α vs. 1/T where ΔΔH and ΔΔS can be extracted by the slope and 
intercept, respectively) the enthalpic and entropic magnitudes can be experimentally obtained.  
 
Generally, the enthalpic values are mostly negative favoring chiral recognition while the 
entropic values tend to be positive counteracting chiral recognition. The opposite absolute 
values of ΔΔHR,S and ΔΔSR,S, which are observed most of the times, assume that chiral 
recognition is usually enthalpically controlled. 
The forms of enthalpic contribution like number and strenght of ionic interactions are better 
investigated in contrary to entropic contributions (solvation effects, re-ordering of SO and 
SA), which are difficult to study.11 
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2.4 Different Types of Chiral Stationary Phases 
 
2.4.1 Polymeric CSPs  
 
2.4.1.1 Polysaccharide Type CSPs  
 
Chiral stationary phases based on natural polysaccharides can be considered as pioneers in 
chromatographic enantiomer separation. They date back to the early 1950s when amino acids 
were resolved on cellulose papers but showing only low enantioselectivity values.12 An 
improvement in enantioselectivity was achieved by the development of microcrystalline 
cellulose triacetate (MCTA). Fusing high enantioselectivity and loading capacities those 
materials were suitable for commercial preparative use and became well known under the 
tradenames CTA-I (Merck) and CHIRALCELL CA-1 (Daicel Chemical Industries, Ltd.) 
New coating techniques on silica support materials and development of further polysaccharide 
derivatives led to an improvement in mechanical stability and enlarged the spectra of chiral 
analytes to be resolved.13 These CSPs can be operated in normal mode, polar organic and in 
reversed phase mode. 
The introduction of aromatic substituents on cellulose and amylose materials created CSPs 
which were able to resolve a broad range of chemically diverse chiral analytes.14 Especially 
cellulose and amylose tris(3,5-dimethylphenylcarbamates), which are sold under the trade 
names CHIRALCEL® OD and CHIRALPAK® AD, are currently among the most often 
applicated CSPs.  
Despite of the positive aspects stated before these CSPs have still the disadvantage of 
instability in non standard mobile phases like dichloromethane, chloroform, tetrahydrofurane, 
toluene, dioxane, ethylacetate etc. as the polysaccharide is only adsorbed and not covalently 
attached to the silica support material. Operation with that kind of mobile phases causes 
changes in the tertiary structure and even dissolution of the stationary phase.  
Therefore, dedicated research was made to invent new immobilization techniques. Hence, a 
new strategy containing a photochemical and thermal cross-linking in presence of a free 
radical initator was established obtaining new CSPs with stability towards all kinds of mobile 
phases.15 
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Widely spread polysaccharide phases like CHIRALCEL and CHIRALPAK were improved by 
using the novel immobilization technique enlarging their application modes. Thus, these types 
of polysaccharide-based CSPs are market leaders and can be considered as the currently most 
important tools in chromatographic enantiomer separation.  
However, one negative aspect of polysaccharide-based CSPs is the limited understanding of 
the molecular chiral recognition process. Studies pointed out the importance of the helical 
supramolecular structure of cellulose- and amylose-tris(phenylcarbamate) derivatives for 
chiral recognition.16 But detailed studies regarding chiral recognition on a molecular level are 
hardly realizable as polysaccharides show low solubility in solvents which favor chiral 
recognition or give badly resolved NMR spectra because of shift averaging. Another 
disadvantage is the great number of binding interactions between the single glucose 
monomers and the analytes which aggravates spectroscopic studies.  
For this reasons systematic selector design is almost impossible and developments of new 
polysaccharide stationary phases are rather based on a “trial and error” principle.  
 
 
2.4.1.2 Protein Type CSPs  
 
Proteins immobilized onto support materials (most often silica) also play a role in 
chromatographic enantiomer separation. Protein selectors of commercial relevance are α1-
acid glycoprotein (AGB), human serum albumin (HSA), bovine serum albumin (BSA), 
chicken ovomucoid (OMCHI) and cellobiohydrolase I (CHB I).7 Especially the AGP-based 
CSPs are of  biggest importance because they were found to resolve the broadest range of  
chiral compounds.17  
Protein-type CSPs have relevance in bioanalytical chemistry exploiting their broad 
enantiomer separation abilities towards chiral drugs and drug-like molecules.18 They are also 
used for studies on protein-drug binding interactions like determination of equilibrium 
binding constants or binding kinetics.  
However, operation of protein based CSPs is strongly limited in several aspects. They are 
only applicable in aqueous mobile phases (reversed phase conditions) and within a certain 
pH-range to avoid denaturation. The possibility of biodegradation, low analytical loading 
capacity because of rather poor selector coverage and complex method development are other 
negative aspects which are limiting the application of protein-type CSPs for commercial use.  
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2.4.1.3 CSPs based on synthetic polymers  
 
Among numerous synthetic polymeric chiral stationary phases of more or less promising 
enantioselectivities and commercial importance one special type is selected and introduced in 
this chapter, the concept of molecularly imprinted polymers (MIPs). In contrast to the CSPs 
described in the previous chapters the MIP-CSP is designed target-specifically. The 
preparation of MIPs comprises the equilibration of the SA (the template) with an excess of 
monomer, a cross-linking agent and a porogenic solvent. The monomers accumulate around 
the SA and form noncovalent complexes. After equilibration polymerization (thermal or 
photochemical) is started. When the polymerization process is finished the templates will be 
eluted obtaining a polymeric CSP with defined cavities in form of negatives of the templates. 
These molecular imprinted polymers are simple in preparation, show chemical stability and 
are applicable for a broad range of chiral analytes.19 
However, a main disadvantage of MIPs is their low binding site density. The bulk 
polymerization process leads to big particles and low mass transfer properties (which is 
chromatographically recognized as peak tailing). This problem was adressed by replacement 
of the bulk polymerization process with polymerization on preformed particles of unique size 
and the use of monolithic stationary phases, respectively. In spite of these improvements 
MIPs are still not competitive to meanwhile well established CSPs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14
2.4.2 Macrocyclic CSPs  
 
Macrocyclic CSPs represent the field of intermediate molecular weight selectors and comprise 
cyclodextrin-type, antibiotic glycopeptide-type and crown ether-type CSPs. Cyclodextrines 
are basket-shaped D-(+)-glucopyranose oligomers consisting of either six, seven or eight 
monosaccharides. They have been used for chromatographic enantiomer separation for a long 
time.20 Cyclodextrine-type CSPs which are prepared by covalent attachment of the 
cyclodextrine SO onto modified silica can be operated in normal phase mode, polar organic 
mode or reversed phase mode.  
Macrocyclic CSPs based on glycopeptide antiobiotics are of particular commercial interest. 
Substances like vancomycin (Figure 2.3), teicoplanine, the aglycon of teicoplanine (TAG) 
and ristocetin A are primarily investigated and used as chiral selectors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Structure of vancomycin 
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Vancomycin (and also the antibiotics named before which are similar in structure) possesses a 
basket-shaped framework and shows a variety of functional groups and aromatic moieties 
providing potential interaction possibilities for chiral analytes. On the other hand, the 
complexity of these molecules aggravates the molecular recognition understanding. 
Glycopeptide antibiotic CSPs operated in reversed phase and polar organic phase mode 
exhibit excellent enantiomer separation performance. A large variety of organic compounds – 
among other things underivatized amino acids – can be resolved.21  
Another advantage of these phases is their so-called overlapping substrate specificitiy which 
means that a poorly resolved analyte on one antibiotic-type CSP may be well separated using 
another, similar antibiotic CSP.22 
 
Another important species of macromolecular chiral stationary phases is that of crown ether-
type CSPs. One crown ether-type selector – a bis-(1,1’-binaphthyl)crown ether – is depicted 
in Figure 2.4. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: (3,3’-diphenyl-1,1’-binaphtyl)-20-crown-6 
 
Most important selector-selectand interaction is hydrogen bonding, for instance, between the 
ether oxygens of the crown ether and the hydrogens of an amino group. Thus, this class of 
CSP is suitable for enantiomer separation of the narrow range of amines, amino acids and 
amino acid derivates, which has been successfully proven.23  
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2.4.3 Low Molecular Weight CSPs 
 
Synthetic or semisynthetic chiral selectors of a molecular weight smaller than of macrocycles 
and which are attached onto a support material are referred to as low molecular weight CSPs. 
They have distinct advantages compared to high- and intermediate molecular weight CSPs. 
Low molecular weight SOs show definite and clearly arranged binding interactions with the 
selectands and, thus, are the selectors of choice for investigations of molecular recognition 
mechanisms. The simplicity of this SO type allows accurate and target-orientated selector 
design enabling resolution of specific analytes. The selectors require little space when being 
attached onto a support material which enables high selector coverage and, consequently, high 
loading capacity. Moreover, low molecular weight SOs are usually available in both 
enantiomeric forms facilitating a switch in elution orders of the resolved analytes.  
CSPs with selectors being covalently attached to the surface of a modified silica gel are 
referred to as brush type phases. They are highly resistant to chemical and physical stress 
because of stable covalent bindings to the silica support material.  
 
 
2.4.3.1 Donor – Acceptor Type CSPs  
 
This type of low molecular weight selector interacts with analytes via nonionic interactions 
such as hydrogen bonding, π-π stacking, dipole-dipole stacking and steric interactions. A 
donor-acceptor type SO became the first commercialized CSP designed by the Pirkle group. It 
is known under the trade name DNBPG® and is depicted in Figure 2.5. 
 
 
 
 
 
 
 
 
 
Figure 2.5  
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According to their limited functional groups these selectors are only feasible for a few classes 
of analytes, in particular those bearing an aromatic moiety. Furthermore, operation of these 
phases is limited to normal phase conditions because highly polar and protic solvents disturb 
the chiral recognition process. 
 
 
2.4.3.2 Ion Exchanger CSPs  
 
The principle of ion exchange selectors is based on ion pairing interactions between the SO 
and the chiral analyte as main interaction force. A prerequisite for an enantioselective ion 
exchange process are ionizable groups within the chiral selector (and within the analytes, 
respectively). Within this chapter ion exchange SOs based on synthetic or semisynthetic low 
molecular weight scaffolds are presented because they are considered as commercially most 
relevant. Apart from electrostatic interactions as dominating long range attractive force there 
exist additional attractive and / or repulsive interactions like hydrogen bonding, π-π stacking, 
dipole-dipole stacking or steric interactions, which may finally enable enantiodiscrimination.  
Intensive and thourough research has been made by our group designing and preparing brush 
type chiral ion exchanger stationary phases. Quinine and Quinidine O9 carbamate 
selectors covalently attached onto silica showed high resolution values for numerous chiral 
acids.24 The most promising one, O9-tert-butyl carbamoylated quinine, is illustrated in Figure 
2.6.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: O9-tert-butyl carbamoylated quinine 
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The cinchona alkaloids quinine (QN) (8R, 9S) and the diastereomer quinidine (QD) (8S, 9R), 
which are serving as scaffolds for the ion exchanger SO, are advantageous in several aspects. 
First of all, quinine and quinidine show pseudoenantiomeric behaviour which results in 
reversal of elution orders when switching from a QN-CSP to a QD-CSP.25 This can be of 
practical relevance when having the choice of eluting the desired analyte enantiomer first or 
second – especially when it comes to preparative separations, detection and quantification of 
minor enantiomeric impurities. Furthermore, the QN / QD scaffold provides well accessible 
binding interactions. The protonated tertiary amine in the quinuclidine moiety serves as a 
weak anion exchanger as primary interaction force, whereas the quinoline moiety provides 
possibilities for π-π stacking and the carbamate modification at O9 offers possibilities for 
hydrogen bonding as secondary, supportive interaction modes.7  Additionally, the bulky tert-
butyl substituent can favour enantiomer separation.26  
The quinine and quinidine based anion exchange CSPs (which are from now on referred to as 
QN-AX CSP and QD-AX CSP, respectively) show high chemical and mechanical stability 
under liquid chromatographic conditions.26 Both CSPs are used in analytical and preparative 
scale and have been comercialized by Chiral Technology Europe (Strasbourg, France) 
(CHIRALPAK® QN-AX and CHIRALPAK® QD-AX).  
For chromatographic evaluation buffered reversed phase and buffered polar organic mobile 
phases are applied.27 By varying concentration and type of the buffer salts as well as the type 
of organic solvent retention and enantioselectivity can be tuned.   
Complementary to QN-AX CSPs cation exchange (CX)-type CSPs based on synthetic low 
molecular weight scaffolds have been recently prepared.28 The CX-SO is depicted in Figure 
2.7  
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Cation exchange-type CSP 
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The sulfonic acid moiety serves as a strong cation exchanger and, thus, forms ion pairing 
interactions with basic compounds like chiral amines or aminoalcohols. The electrostatic 
interactions are supported by SO-SA π-π interactions or hydrogen bonding. In analogon to 
QN-AX phases inversion of stereoconfiguration at the chiral SO leads to reversal of elution 
order of separated analytes.28 This CSP achieved baseline separation for a diverse set of basic 
chiral analytes in combination with high peak efficiencies.  
Like QN-AX CSPs cation exchange phases are preferably operated in buffered polar organic 
mobile phases. Acidic additives create a slightly acidic mobile phase to protonate the basic 
analytes which is required for SO-SA electrostatic interactions.  
To conclude, the concept of brush type ion exchange phases partially shows excellent 
enantioselectivity. In combination with high physicochemical stability and loading capacity 
they are predestinated for preparative enantiomer separation. However, the respective CSP 
(either CX or AX) can only be applied for analytes of opposite charge which is limiting the 
field of application.  
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2.5 Enantiomer Separation of Amino Acids  
 
An extra chapter is dedicated to enantiomer separation of amino acids as a very important 
class of organic compounds. Also synthesis of the chiral selectors for this diploma work 
concentrated on enantioseparation of amphoteric analytes like underivatized amino acids. 
Nowadays direct amino acid separation is feasible on macrocyclic glycopeptide-, crown ether 
type- and protein-type CS Ps, which have been mentioned in the previous chapters. However, 
now the attention is turned to ligand exchange-type CSPs, the historically oldest CSPs ever. 
The ligand exchange technique was developed by Davankov et al. being the first who has ever 
achieved baseline separation of chiral analytes and being the first completely resolving 
racemic amino acids.29 Moreover, ligand exchange phases became the first comercially 
available CSPs and were the method of choice for separation of amino acids in the beginning 
era of enantioseparation.  
The principle of ligand exchange chromatography is based on formation of transient 
diastereomeric metal complexes whose different thermodynamical stabilities and formation 
rates are leading to different retention times. The ternary metal complexes consist of a 
bidentate chiral ligand which is attached to a stationary phase, a transition-metal ion and 
another chiral (racemic) ligand being the analyte. Rigid cyclic amino acids like proline or 
hydroxyproline are most often used as ligand attached to the solid phase support.  
As divalent, chelating metal ions Cu (II), Ni (II), Zn (II), Cd (II) and Hg (II) can be used with 
Cu (II) being preferentially employed.30 The Cu (II) ions are generally added to the aqueous 
mobile phase (most often water-methanol mixtures are applied) together with the racemic 
analytes. After isocratic elution Cu (II) is removed from the separated enantiomer. Fullfilling 
the prerequisite of bivalent chiral selectors most often amino acids are used, for example L-
hydroxyproline in the commercial Nucleosil Chiral-1 column. 
The chelate complex is then formed by coordination of the chiral selector ligand and one 
enantiomer of the injected racemate to the copper ion. Additionally, the complex is stabilized 
by coordination of solvent molecules to the metal ion in axial positions. Stereoconfiguration 
of the chelated analyte enantiomer can either enforce or weaken solvent coordination which 
results in different kinetic and thermodynamic stability between the diastereomeric 
complexes.  
Figure 2.8 shows a model for such complexes.  
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Figure 2.8: Model for complex of proline enantiomers on L-hydroxyproline selector 
 
Regarding Figure 2.8, one can see that the complex formed with the L-Proline enantiomer is 
of less stability because of steric interactions with the coordinated water molecule (used as 
solvent). Therefore, retention of L-proline will be lower than that of D-proline.  
Generally, additional intermolecular interactions like π- π interactions, hydrophobic effects or 
hydrogen bonding may also occur and contribute to differences in free energies of the 
diastereomeric complexes.  
For obtaining high resolution it is necessary to guarantee fast kinetics (fast formation and 
dissociation of the diastereomeric complexes). This can be achieved by selection of 
appropriate metal-ions and positioning of the electron donor groups of the chiral selector. 
Additionally, the system can be optimized by increasing column temperature and modifying 
solvent composition and mobile phase pH.31  
Nevertheless, poor efficiency still remains a main problem due to low rate of ligand exchange 
reactions. Generally, one can say that ligand exchange chromatography is characterized by 
excellent enantioselectivity but rather poor column efficiency.30  
The limited application for just bidentate (tridentate) analytes and labor intensive method 
development for obtaining adequate separations are another reasons why ligand exchange 
chromatography has lost commercial relevance compared to e.g. polysaccharide  based CSPs. 
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3 Design and Synthesis of Novel Chiral Zwitterionic Ion  
Exchange Stationary Phases    
 
The main synthetic focus of the diploma work was on the development of novel zwitterionic 
chiral stationary phases. The fundamental idea was to fuse chiral anion and cation exchange 
units into one single zwitterionic selector.  
Therefore, well established chiral weak anion exchangers (WAX) based on cinchona alkaloid 
derivatives (like Chiralpak® QD-AX and Chiralpak QN-AX Lindner phase columns) were 
merged with recently investigated strong cation exchange (SCX) chiral stationary phases 
(CSPs)28.  
Figure 3.1 visualizes the concept of the zwitterionic CSPs. 
 
                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 
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The sulfonic acid based strong cation exchange-type (SCX) CSP shown in Figure 3.1 has 
proven to be a powerful tool in enantioselective separation of chiral amines. On the other 
hand, quinine/quinidine based carbamoylated weak anion exchange CSPs are capable to 
separate a great many of chiral acids. As a logical consequence, the idea came up to fuse these 
acidic and basic SO units into novel zwitterionic chiral SOs. 
Previous investigations showed that the C9-position of quinine and of its pseudoenantiomer 
quinidine is of vital importance for chiral molecular recognition and, therefore, chiral 
separation ability.25, 32 As a matter of this it was suggested to leave the C9 configuration 
unaltered and new acidic functionalities were introduced via chemically stable carbamate 
linkages. 
Several quinine based selectors have been prepared by our group varying acidic cation 
exchange units to make thorough chromatographic investigations possible.33  
Hence, the synthetic work was not only limited in introducing new acidic moieties into 
cinchona scaffolds but also varying other crucial units of these novel zwitterionic CSPs.  
Figure 3.2 gives an overview of all synthesized CSPs. 
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Table 3.1 shows the short names, full names and the selector coverages of the synthesized 
CSPs. The short names are referred to throughout the rest of the chapters. All colums were 
packed in house.  
 
 
    
CSP Number Short Name Full Name 
Coverage µmol 
[SO] g-1 [CSP] 
        
CSP 1 Tau-QD taurine-quinidine  210 
        
        
CSP 2 L-CSA-QN L-cysteic acid-quinine  240 
        
        
CSP 3 Quinu-QD quinuclidine-quinidine 218  
        
        
CSP 4 
Tau-N-Methyl-
QN taurine-1-N-methyl-quinine  105 
        
        
CSP 5 Tau-Quinc taurine-quincorine  290 
        
        
CSP 6 
L-CSAD-DH-
QN 
amido-L-cysteic acid-
dihydroquinine  260 
    
    
 
 
The aim was to prepare CSPs with selector loadings at about 200 µmol g-1. In fact, the actual 
coverages vary between 105 and 255 µmol g-1. Possible reasons for these fluctuations will be 
discussed on the following pages.  
However, previous investigations in our group showed that selector density affects retention 
(higher selector loadings means having more possibilities for selector – analyte interactions 
and, therefore, increases retention time) but not so much enantioselectivity value α and 
enantiomeric separation can be achieved with SO loadings down to 100 µmol g-1.  
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As it was stated before, the main focus was on varying the AX and CX moieties within the 
zwitterionic SO to create a new basis for posing more questions on the molecular recognition 
mechanism.  
CSP 1 (Tau-QD) was primarily prepared for comparison with previously synthesized Tau-QN 
The comparison of SOs which only differ in their cinchona alkaloid scaffold (quinidine versus 
its pseudoenantiomeric form quinine) should confirm previous investigations in obtaining 
reversed enantiomer elution orders when switching from a quinine to a quinidine based SOs. 
It should be tested if this behaviour is maintained in the concept of these novel zwitterionic 
CSPs. 
 
Chromatographic investigations on zwitterionic CSPs bearing a second acidic functionality 
led to the design of L-CSA-QN (CSP 2). In this case an additional carboxylic functionality 
was introduced whose effects on enantiomer separation should be investigated. Moreover, the 
L-cysteic acid site created another stereogenic center apart from the C8 and C9 centers of 
quinine. It was interesting to see how far this case would affect separation of enantiomers. 
 
CSP 3 differs from the  zwitterionic CSP scheme, so it is a “double anion exchange CSP”. It 
was mainly synthesized to compare it with standard QN/QD-AX CSP (Chiralpak® QD-AX 
and Chiralpak® QN-AX) phases to evaluate how a second anion exchanger site affects 
enantioselectivity and retention, of course. Another aspect was if this bisbasic CSP is able to 
coordinate bisacidic analytes via double ion pairing in analogon to zwitterionic CSPs which 
are coordinating amphoteric analytes. 
 
CSP 4 could be seen as the strong anion exchange (SAX) analog to Tau-QN. It was 
methylated at the quinuclidine nitrogen position in order to obtain a quaternary ammonium 
ion and hence, a strong anion exchange binding site.  So far, strong cation exchange (SCX) 
sites like sulfonic acids turned out to be the more powerful selector than for example weak 
cation exchangers like carboxylic acids. As a consequence, it has to be investigated if a strong 
anion exchanger is able to improve enantiomeric separation as well. 
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Furthermore, the effect of π-π interactions for enantiomeric separation was a topic of detailed 
analysis. For this reason Tau-Quinc (CSP 5), which is characterized by a missing quinoline 
moiety, was synthesized. As π-π interactions are seen as an important factor for enantiomeric 
separation of aromatic analytes it was interesting to see wether enantiomeric separation is 
degraded or not. Another important aspect was how the missing quinoline moiety would 
affect separation of non aromatic analytes.  
 
At last steric aspects were taken into consideration in preparing the L-CSAD-DH-QN selector 
(CSP 6). It is a modification of the carboxylic group of the L-cysteic acid moiety and could 
have also been made with L-CSA-QN (CSP 2). Because of the dihydroquinine scaffold a 
double bond for SO immobilization had to be introduced via allylamine coupling. With the 
preparation of CSP 6 it was hoped to get new ideas how a more volatile SO (because of the 
completely different binding site between SO and silica) would influence enantioselectivity 
values.  
 
On the whole, this overview should only give an idea on the background of the sythesized 
CSPs. More specific details according to the SO`s structure and its impact on enantiomeric 
separation will be discussed in the chromatography chapter.  
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3.1 Synthesis of Tau-QD (CSP 1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.1: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1) 
taurine, BSA, CH2Cl2, reflux, 24 h,   2) 2, CH2Cl2, r.t., 24 h  (c) AIBN, MeOH, reflux, 5 h. 
 
 
Scheme 3.1 shows the synthetic route to novel CSP 1. Commercially available quinidine 1 
was transformed into its activated ester hydrochloride 2 by reaction with of 4-nitrophenyl 
chloroformate. The starting material had to be used as free base to achieve quantitative yields 
of 2 because of precipitation of the product (purification by chromatography would not have 
been possible due to instability). The activated ester is slightly sensitive to hydrolysis and 
should be stored under inert gas. The zwitterionic taurine-quinidine selector 3 was achieved 
by reaction of the silylated taurine with the activated ester hydrochloride 2. First it was 
necessary to silylate taurine with O,N-bis(trimethylsilyl)acetamide (BSA) to avoid solubility 
problems due to inner salt formation. After that, nucleophilic addition of the silylated taurine 
to the activated ester hydrochloride led to novel taurine-quinidine selector 3. It has turned out 
that only complete silylation (clear solution indicates complete silylation) of the 
corresponding amino acid led to high yields of the zwitterionic selector.  
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Compound 3 was purified by flash chromatography especially for removing acetamide, a 
byproduct that is formed from the silylating reagent.  
Reaction step c was the most crucial one in synthesis of the CSP. Covalent selector 
immobilization was carried out via radical addition of the thiol-modified silica with the 
double bond of the taurine-quinidine selector. Experimental investigations showed that high 
selector loadings can only be achieved by using as little solvent as possible. What is more, the 
structure of the selector (zwitterionic, bisbasic, bisacidic) could have some influence on 
immobilization, too.  
Therefore, it was generally not possible to create CSPs with equal selector loadings and they 
varied between 105 and 255 μmol g-1 whereas the low number was actually the exception. 
 
 
 
 
3.2 Synthesis of L-CSA-QN (CSP 2)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.2: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1) L-
cysteic acid, BSA, CH2Cl2, reflux, 48 h, 2) 5, CH2Cl2, r.t., 24 h  (c) AIBN, MeOH, reflux, 5 h. 
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Synthesis of L-CSA-QN (CSP 2) was similar to the preparation of CSP 1. This time the base 
free of quinine 4 was used as a starting material instead of quinidine. Addition of 4-
nitrophenyl chloroformate led to quinine activated ester hydrochloride 5. For getting the 
desired L-cysteic-QN selector 6 it was also necessary to convert the enantiomerically pure L-
cysteic acid in its silylated form by addition of BSA. Nucleophilic additon of the silylated L-
cysteic acid to the activated ester hydrochloride 5 led to L-cysteic acid quinine selector 6. 
When quenching this reaction with MeOH (as it was done when synthesizing CSP 1) a 
viscous, polymer-like substance was usually formed. This residue could only be redissolved 
in MeOH and spectroscopic investigations showed that it was pure L-CSA-QN selector 6. As 
a consequence, when carrying out these reaction again it was done without purification by 
flash chromatography to avoid unnecessary loss of product. When preparing CSP 2 selector 
immobilization was carried out in completely the same way as it was done in Scheme 3.1.  
 
 
 
3.3 Synthesis of Quinu-QD (CSP 3)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.3: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b)            
3-aminoquinuchlidine (racemic mixture), CH2Cl2, r.t., over night, (c) AIBN, MeOH, reflux,5 
h.  
N
OMe
HO N
(9S)
(8R)
O
N
OMe
O NO
O2N
Cl
H
O
N
OMe
O N
O
O
Si
H3C
S
O
N
OMe
O N
H
N
a b
c
N
H
N
N
1 2
7 CSP 3
(8R)
(8R) (8R)
(9S)
(9S) (9S)
 30
 
Scheme 3.3 shows the synthetic route to Quinu-QD (CSP 3). This CSP consists of two anion 
exchanger moieties instead of one AX and one CX moiety and is not zwitterionic anymore. It 
was designed to investigate enantiomeric separation behaviour for acidic analytes (especially 
analytes with two acidic functionalities) which will be discussed more detailed in the 
chromatography chapter.  
Step a and b of the synthetic scheme followed standard procedures as described for CSP 1 
and 2, respectively. The quinuclidine-quinidine SO 7 was obtained by nucleophilic addition of 
a racemic mixture of the free base of 3-aminoquinuchlidine to activated quinidine ester 
hydrochloride 2. Because a racemic reagent was used two diastereomeric selectors were 
produced and immobilized. For the investigation of basic properties of this bisbasic CSP the 
use of a racemic selector was adequate.  
 
 
 
 
 
3.4 Synthesis of Tau-N-Methyl-QN (CSP 4)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.4: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1) 
taurine, BSA, CH2Cl2, reflux, 24 h, 2) 5, CH2Cl2, r.t., 48 h,  (c) 1) KOH, MeOH  2) MeI, DMF, 
r.t., 60 h, (d) AIBN, MeOH, reflux, 5 h.  
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During the preparation of Tau-N-Methyl-QN (CSP 4) steps a and b followed standard 
procedures. Although this time Tau-QN 8 was synthesized instead of Tau-QD 2 no 
differences were noticed in practical synthetic work which is probably another aspect of the 
pseudoenantiomeric behaviour of quinine and quinidine.  
However, quaternization of the quinuclidine nitrogen by methylation (step c) turned out to be 
not as straightforward as expected. Several attempts were tried varying solvents (switching 
from the protic solvent MeOH to aprotic solvents like CH2Cl2 and DMF), temperature and 
reaction time without any satisfying results. It was concluded that compound 8 in its 
zwitterionic form (meaning that sulfonic acid is deprotonated and the quinuclidine nitrogen is 
therefore protonated) is not accessible for alkylation. A protonated quinuclidine nitrogen 
transforms the tertiary amine into a quaternary one which is badly accessible for methylation, 
of course. Therefore, compound 8 had been transformed into its potassium salt before it was 
subjected to methylation.  
Despite of varying reaction parameters like temperature, reaction time and equivalents of 
iodomethane no satisfying results could be obtained. The desired product 9 was always 
accompagnied by species with additional methylation at the carbamate nitrogen on one hand 
and non methylated, unreacted educt on the other hand (it must be pointed out that under such 
reaction conditions no methylation at the quinoline nitrogen occurs).34 Therefore, the product 
mixture was purified by preparative RP-HPLC (reversed phase conditions had to be used 
because the very polar products could not be eluted on normal phase silica any more) 
obtaining pure compound 9.  
Unfortunately, immobilization of the Tau-N-Methyl-QN selector wasn`t working as expected 
where a selector loading of only 105 μmol g-1 could be achieved. One possible explanation 
could be that the quaternary nitrogen affects radical addition negatively. This case has to be 
subjected to further investigations which couldn`t have been carried out any more. 
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3.5 Synthesis of Tau-Quinc (CSP 5)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.5: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1) 
taurine, BSA, CH2Cl2, reflux, over night, 2) 11, CH2Cl2, r.t., 40 h,  (c) AIBN, MeOH, reflux, 5 
h. 
  
Scheme 3.5 gives an overview of the synthetic route to CSP 5. At first sight one can see that 
with the quinoline moiety a significant part of the alkaloid motif is missing. So this CSP was 
designed to make investigations on how a missing position for π-π interactions affects 
enantiomer separation ability of zwitterionic CSPs. For the synthesis quincorine 10 was used 
as starting material (its pseudoenantiomeric form quincoridine is principally available, too). 
Addition of 4-nitrophenyl chloroformate led to activated quincorine ester hydrochloride 11 (a 
white solid - similar to previous activated quinine and quinidine esters - was formed which 
could easily be filtrated off). Preparation of the Tau-Quinc selector 12 followed the same 
procedure as it was carried out for the quinine/quinidine selectors. However, purification by 
flash chromatography was hampered because of missing UV-light absorption of the product 
and no colouring reagents could be found to make the product spots visible. Therefore, the use 
of flash chromatography was limited to the removal of the 4-nitrophenol byproduct. 
Acetamide as another byproduct was removed by iterative trituration using acetone. This 
purification process turned out to be sufficient regarding the following immobilization leading 
to CSP 5, which was obtained in a high selector loading of 290 μmol g-1. 
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3.6 Synthesis of L-CSAD-DH-QN (CSP 6)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.6: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1) L-
cysteic acid monohydrate, BSA, CH2Cl2, reflux, 24 h, 2) 14, CH2Cl2, r.t., 60 h,  (c) allylamine, 
DCC, DMF, r.t., 70 h, (d) AIBN, MeOH, reflux, 5 h.  
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Scheme 3.6 shows the synthetic route of CSP 6. The goal was to create a selector with a 
completely different binding position to the silica compared to the other CSPs shown in Table 
3.1. Since an olefinic double bond is required for radical addition it had to be introduced 
elsewhere within the selector molecule while the olefine group on the alkaloid substructure 
had to be eliminated to avoid double immobilization and inhomogeneous selector structures 
on the surface of the stationary phase. Therefore, dihydroquinine 13 with a saturated ethyl 
group in 3-position was used as convenient starting material (in its base free form). Steps a 
and b were carried out in meanwhile well known synthetic procedures as they were applied 
for preparation of CSP 2. However, it has to be noted that L-cysteic acid was not 
commercially available any more, so L-cysteic acid monohydrate had to be used instead in 
connection with a high excess of BSA to absorb undesired amounts of water.  
For preparing the L-CSAD-DH-QN selector 16 several attempts for the allylamine coupling 
were carried out. Generally, no quantitative yields for the amide formation could be obtained. 
One explanation may be found in a sterically difficult access to the carboxylic function. The 
use of DCC as coupling reagent in combination with DMF as solvent was the best 
compromise regarding practical synthetic work and yield. Compound 16 was not purified by 
flash chromatography because of very close elution times of educt and product in a variety of 
eluent systems. Therefore, impurities due to unreacted starting material were accepted when 
doing the final immobilization step d because only the desired product was expected to be 
immobilized leading to CSP 6.  
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3.7 Synthesis of Selectors of non-realized CSPs 
 
 
 
3.7.1 Synthesis of DACH-QD  
 
 
At the beginning of my diploma work a selector with purely AX character similar to CSP 3 
was synthesized, as outlined in Scheme 3.7. It could either be seen as an AX-analog to a 
previously prepared SCX-type CSP (see Figure 3.1), which is bears a sulfonic acid group 
instead of the amino group, or as supplementary derivative of the Quinu-QD type, now having 
a primary amine as the second AX site. The DACH-QD (diaminocyclohexane-quinidine) 
selector 17 was also designed as a promising building block employing the cyclohexane motif 
for synthetic concepts based on the primary amino group as functional group for further 
modifications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.7: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1R,2R-
diaminocyclohexane, , CH2Cl2, r.t., over night  (c) AIBN, MeOH, reflux, 5 h. 
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The DACH-QD selector 17 was prepared by nucleophilic addition of enantiomerically pure 
diaminocyclohexane to activated quinidine ester hydrochloride 2. After the standard 
immobilization step, however, no significant increase of nitrogen content was measured in the 
elemental analysis of the resulting silica material, indicating that no covalent selector 
attachment had taken place. LC-MS analysis of the reaction filtrate revealed that bisamine 17 
had been converted completely to starting material quinidine 1. In contrast to all other C9-
carbamate-type CSPs in this study, the carbamate of 17 is obviously not stable under the 
immobilization conditions of MeOH at reflux. Due to proximity, an attack of the primary 
amino group at the carbamate carbonyl group could be a possible explanation although the 
resulting cyclic urea species has not been detected in MS. For the purpose of a better 
understanding of the observations on selector 17 stability tests were carried out where 
variations of solvents and reaction times were accomplished. The studies clearly showed that 
in an aprotic solvent like CH2Cl2 the selector remained unaltered during the immobilization 
process indicating that protic MeOH could be involved in the carbamate cleavage. Although  
successful alternative reaction conditions were hence established, the immobilization was not 
repeated on a larger scale in an aprotic solvent that would yield enough CSP for packing a 
column because of  lack of selector 17 while syntheses of other CSPs were preferred.  
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3.7.2  Synthesis of D-CSA-QN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.8: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b) 1) L-
cysteic acid, BSA, CH2Cl2, reflux, 24 h, 2) 5, CH2Cl2, r.t., 24 h,  (c) diasteromer separation on 
Tau-QD type CSP, (d) AIBN, MeOH, reflux, 5 h. 
 
 
 
Scheme 3.8. gives an overview of another unrealized CSP. The D-CSA-QN selector 20 would 
have been synthesized to obtain the diastereomeric form of CSP 2. Differences in enantiomer 
separation ability between L- and D-CSA-QN would have been investigated. Though, after 
preparing the mix of diastereomers of selector 19 according to procedures as they were 
applied for CSP 2 the diastereomer separation turned out not to be feasible: No satisfying 
separation was achieved on a QN-AX CSP which was available in dimensions for preparative 
scale.  
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A satisfying separation of the two diastereomers was established only on Tau-QD (CSP 1) 
where parameters could be optimized.  
However, this CSP was available only in analytical dimensions, and in combination with the 
poor solubility of the mixture of 19 a productive chromatographic separation was not 
practical.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 39
4 Evaluation of Novel Chiral Zwitterionic Ion Exchange 
Stationary Phases    
 
In this chapter the results of the chromatographic evaluations of CSP 1 – CSP 6 are 
presented. Chromatographic parameters like retention factor k, selectivity coefficient αji, plate 
number N and resolution RS are discussed. First of all, a principal evaluation will be made of 
all CSPs regarding the chromatographic parameters and in later sections a more detailed 
comparison between single columns will be shown. 
 
 
4.1 Experimental   
 
Chromatographic measurements were carried out on a 1100 Series HPLC system from 
Agilent Technologies (Waldbronn, Germany) equipped with an autosampler, binary pump, 
degasser for the mobile phase, multiple wavelength detector (MWD) and a 6-column 
switching valve. For analytes with weak UV-absorbance properties a corona charged aerosol 
detector (CAD) from ESA Biosciences, Inc. (Chelmford, USA) was used instead. An Agilent 
1200 series 2/10-valve for switching between waste and recycle mode was used as well for 
the purpose of solvent economy: The waste position was chosen when switching from one 
column to another and for column conditioning, while recycle mode was used for analysis in 
order to save solvents. After use the columns were washed and stored in MeOH.  
Data analysis was carried out with Chemstation chromatographic data software from Agilent 
Technologies. Elution was performed in isocratic mode at a mobile phase flow rate of 1.0 
ml/min. The void volumes of the columns were determined by injecting acetone with 
detection at 230 nm. For chromatographic measurements no thermostat was used and 
therefore, temperature may have varied between 25° and 30°C. UV-detection was 
accomplished at selected wavelengths between 230 and 280 nm. All analytes were applied as 
methanolic solutions in concentrations between 1.0 – 3.0 mg/ml. To determine elution orders 
of selected solute enantiomers either single enantiomers or enantioenriched samples of known 
absolute configuration were injected.   
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4.2 Mobile Phases 
 
Generally, mobile phase composition is one of the most important tuning parameters in 
HPLC. In conventional ion exchange chromatography the elution strength is strongly 
influenced by varying concentrations of co- and counterions or by changing the pH-value and, 
therefore, the charge of ionic solutes in aqueous systems.  
In the case of ion exchange chromatography using zwitterionic CSPs, polar organic mobile 
phases were used. They consist of the bulk solvent methanol with acidic and basic additives 
that act as co- and counterions. This kind of mobile phase composition has been thouroughly 
studied by our group when investigating CSPs of purely anionic or cationic character.28, 32 
For better comparison of the chromatographic data being displayed in this chapter one 
common mobile phase for all columns was applied and no mobile phase optimizations were 
carried out. The analytes were measured using a mobile phase composition of methanol as 
bulk solvent and 25 mM acetic acid (HOAc) and 25 mM ammonium acetate (NH4Ac) as 
additives.  
 
4.3 Analytes 
 
The main goal of designing and synthesizing novel brush type zwitterionic chiral stationary 
phases was to enable enantiomer separation for amphoteric analytes (see Fig. 4.1). Therefore, 
a broad range of unprotected amino acids was set up comprising aminoacids with aromatic, 
cyclic and aliphatic side chains, hydroxyl-, thiol-, carboxyl- and sulfonic acid functionalities. 
Not only zwitterionic analytes were chosen for a representative set of analytes but also chiral 
acids and chiral amines. When evaluations with acidic analytes were carried out the goal was 
to evaluate if the cinchona alkaloid based anion exchange properties could be conserved in the 
zwitterionic CSPs. CSP 3 with its “double AX” character was only tested for acidic analytes. 
Hence, a set of eight acidic analytes (see Fig. 4.2) comprising N-protected amino acids with 
commonly used N-derivatizing groups was used. After testing the stereoselectivity between 
the AX-site and acidic analytes a set of chiral amines (see Fig. 4.2) was applied to investigate 
the CX-part. Five chiral pharmacologically relevant bases like β-blockers, β-
sympathomimetics and others were selected to see if the cation exchange motif is still 
working in a zwitterionic CSP.  
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Figure 4.1: Acidic and basic analytes used in the presented chromatography studies 
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Figure 4.2: Zwitterionic analytes 
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4.4 General CSP Comparison  
 
In the general comparison part principal differences of the synthesized CSPs are subject to 
investigation. A brief look will be taken at common chromatographic parameters, namely 
capacity factor k, selectivity coefficent α, plate number N and resolution RS, of course. As 
written above, mobile phase composition throughout all compared data consisted of methanol 
with 25 mM HOAc and 25 mM NH4Ac resulting in a acid to base ratio of 2:1. 
CSP 3 is of purely anion exchange character and will be discussed in an extra chapter. In 
contrary, CSP 4 (Tau-N-Methyl-QN) is of zwitterionic origin but of very low selector loading 
which doesn`t allow to draw conclusions regarding retention and plate numbers. Therefore, 
chromatographic parameters of CSP 4 like enantioselectivity α, which isn`t strongly affected 
by significantly lower selector loadings, will be discussed in an extra chapter. Consequently, 
CSP 3 (Quinu-QD) and CSP 4 (Tau-N-Methyl-QN) weren`t undergone these common 
chromatographic evaluations. 
 
 
4.4.1 Retention Factor k 
 
In the case of ion exchange-type chiral stationary phases under organic mobile phase 
conditions retention factor k reflects the binding strength between the chiral selector and the 
selectand. There are always k1 values shown for separated analytes and for non separated 
analytes the k value of the single peak is denoted. 
As stated before, those four zwitterionic CSPs possessing similar selector loadings are 
compared to each other. One has to take into consideration that selector loading – in other 
words the amount of interaction possibilities between analytes and selector – is mainly 
responsible for retention under the given, nonaqueous polar organic elution conditions. The 
synthesized zwitterionic CSPs differ in 80 µmol g-1 of selector loading which can be 
considered as a quite big difference. Nevertheless, comparison of a Tau-QD CSP with 150 
µmol g-1 of selector loading and that of Tau-QD (CSP 1) with a coverage of 210 µmol g-1 did 
not show significant differences in retention time, which is an indication that the accessible 
selector density may be differing from the amount of immobilized selectors. 
Table 4.1 shows retention factors k1 for all investigated acidic, basic and zwitterionic 
analytes. In Figure 4.3 results of elected analytes are graphically reflected. 
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    k1 Values     
  Tau-QD  L-CSA-QN Tau-Quinc 
L-CSAD-
DH-QN 
  CSP 1 CSP 2 CSP 5 CSP 6 
Selector Loadings 
[µmol g-1] 210 240 290 260 
          
Fmoc-Phe  0,37 0,26 1,63 2,84 
Z-Phe 0,17 0,12 1,13 2,14 
DNP-Phe 0,38 0,36 2,02 3,15 
DNB-Phe 0,25 0,15 1,40 2,25 
Ac-Trp 0,25 0,28 1,68 2,69 
DNB-Glu 0,59 0,49 3,94 9,86 
DNB-Asp 2,85 1,26 5,69 16,50 
Fmoc-Ser 0,35 0,33 1,86 3,05 
          
          
Phe 0,43 0,82 0,34 0,98 
beta-Phe 0,87 1,15 0,30 1,09 
alpha-Me-Phe 0,35 0,63 0,25 0,88 
Trp 0,79 2,03 1,00 1,12 
alpha-Me-Trp 0,75 1,41 0,88 1,40 
1-Me-Trp 0,81 1,72 0,77 1,46 
alpha-Me-DOPA 0,56 1,15 0,60 1,25 
Pro 0,44 0,93 0,30 1,06 
alpha-Me-Pro 0,40 0,58 0,17 0,86 
Azetidinic Acid 0,44 1,27 0,37 1,16 
Nipecotic Acid 0,90 1,93 0,29 1,38 
Pipecolic Acid 0,42 0,73 0,30 0,94 
Cysteic Acid 0,24 0,50 2,48 2,69 
Dimethyltaurine 0,23 1,21 0,43 0,93 
Met 0,46 0,90 0,37 1,04 
Leu 0,31 0,54 0,21 0,80 
tBu-Leu 0,33 0,53 0,19 0,79 
Ser 0,45 1,42 0,42 1,08 
Thr 0,41 0,92 0,32 0,94 
Cys 0,50 /// 0,58 1,10 
Ala-Ala 0,55 1,30 0,42 1,17 
Ala-Val 0,51 1,23 0,41 1,31 
Leu-Leu 0,43 0,93 0,32 1,05 
Pro-Phe 0,87 2,14 0,77 1,94 
          
          
Mefloquine 1,40 3,94 0,19 1,25 
Oxazepam 0,40 0,60 0,36 0,02 
Clenbuterol 1,45 3,35 0,11 0,89 
Noscapine 0,32 0,38 0,21 0,70 
Labetalol 2,72 11,48 0,48 1,73 
     
 
Table 4.1  
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Figure 4.3: k1 diagrams 
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When interpreting the obtained k1 values the influence of different selector loadings has to be 
taken into consideration. Nevertheless, some genereal trends can be derived from Table 4.1. 
Previous investigations on molecular recognition showed that ionic interactions contribute at 
most to retention.35 Therefore, a closer look to acid and basic functionalities of the selectors 
has to be taken. All CSPs presented in the study principally contain a sulfonic acid (strong 
cation exchanger) and a tertiary amine (weak anion exchanger) binding site within the 
selector. CSP 2 provides with its extra carboxylic functionality an additional ionizable group. 
Consequently, it shows stronger retention for the basic amines (at least 3 fold higher than the 
other CSPs) which can be attributed to stronger ionic interactions (because of the additional 
carboxylic group) with the basic amines.   
This conclusion is also confirmed by higher retention factors for amphoteric analytes 
compared to e.g. Tau-QD with only one acidic functionality. As a consequence, CSP 2 shows 
lower retention for acidic N-protected amino acids, wherein the additional acid functionality 
of the SO contributes to increased elution strength. A stronger acid is a more dominant 
counter ion and, consequently, leads to shorter retention times.  
When comparing the three remaining CSPs – namely Tau-QD (CSP 1), Tau-Quinc (CSP 5) 
and L-CSAD-DH-QN (CSP 6) – one could expect similar retention between these phases if 
only ionic interactions were taken into account. However, the observed retention factors are 
differing strongly. Especially L-CSAD-DH-QN (CSP 6) showed stronger retention towards 
all classes of analytes. A possible reason may lie in different steric conditions because of an 
opposite binding site to the silica. Besides, there exist a stereogenic center on the cation 
exchanger site in contrary to CSP 1 and CSP 5 with achiral acidic side chains. However, it is 
not yet clear how far retention time is affected by these factors. Another remarkable fact is 
that the acidic N-derivatized amino acids are stronger retained on Tau-Quinc (CSP 5) than on 
Tau-QD (CSP 1). Altough CSP 5 does not possess any  possibility for aromatic interactions – 
which is seen as another important SO–SA interaction mode – it shows much higher retention 
than CSP 1 whith its aromatic quinoline moiety. Besides, k1 values for zwitterionic analytes 
are roughly equal for both CSP 1 and CSP 5. The chiral amines (all containing aromatic 
functionalities) are even stronger retained on CSP 1 which goes along according to prognosed 
interaction mechanisms.  
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4.4.2 Selectivity Coefficient αji  
 
Generally, α values are an indicator for separation performance of a chromatographic system. 
Regarding chiral stationary phases, α gives information about the stereoselective 
discriminating character of a selector and, thus, its enantioselectivity. High α values are 
desirable because they can allow baseline separation even if unfavorable peak shapes are 
encountered. Especially in preparative chromatography sample loading capacities and the 
grade of flexibility towards mobile phase compositions profit from a higher enantioselectivity.  
In the presented chromatographic evaluations two different retention times were noticed 
whenever a clear valley between two peak maxima was observable and, therefore, α was > 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 48
    α Values     
  Tau-QD  L-CSA-QN Tau-Quinc 
L-CSAD-
DH-QN 
  CSP 1 CSP 2 CSP 5 CSP 6 
          
Fmoc-Phe  1,55 1,33 1,00 1,13 
Z-Phe 1,46 1,00 1,00 1,07 
DNP-Phe 1,78 1,00 1,00 1,06 
DNB-Phe 9,89 6,55 1,00 2,06 
Ac-Trp 3,41 2,52 1,00 1,21 
DNB-Glu 3,82 2,76 1,00 1,74 
DNB-Asp 1,90 1,19 1,00 1,23 
Fmoc-Ser 1,75 1,50 1,00 1,15 
          
          
Phe 1,00 1,00 1,00 1,00 
beta-Phe 1,11 1,00 1,00 1,00 
alpha-Me-Phe 1,26 1,00 1,00 1,00 
Trp 1,82 1,13 1,03 1,49 
alpha-Me-Trp 2,41 2,04 1,05 1,28 
1-Me-Trp 1,20 1,00 1,00 1,00 
alpha-Me-DOPA 1,41 1,16 1,00 1,03 
Pro 1,15 1,00 1,00 1,00 
alpha-Me-Pro 1,25 1,00 1,00 1,00 
Azetidinic Acid 1,16 1,00 1,00 1,16 
Nipecotic Acid 1,24 1,05 1,00 1,06 
Pipecolic Acid 1,00 1,00 1,00 1,00 
Cysteic Acid 1,00 1,00 1,00 1,04 
Dimethyltaurine 1,00 1,00 1,00 1,00 
Met 1,00 1,00 1,00 1,00 
Leu 1,00 1,00 1,00 1,00 
tBu-Leu 1,00 1,00 1,00 1,00 
Ser 1,00 1,00 1,00 1,00 
Thr 1,00 1,00 1,00 1,00 
Cys 1,00  /// 1,00 1,09 
Ala-Ala 1,13 1,17 1,00 1,00 
Ala-Val 1,69 1,29 1,00 1,00 
Leu-Leu 2,72 1,29 1,00 1,17 
Pro-Phe 3,21 1,50 1,00 1,23 
          
          
Mefloquine 1,88 2,45 1,00 1,05 
Oxazepam 1,00 1,00 1,00 1,00 
Clenbuterol 1,03 1,11 1,00 1,00 
Noscapine 1,00 1,00 1,00 1,00 
Labetalol 1,07 1,14 1,00 1,00 
          
  
 
 
 
Table 4.2: Selectivity coefficients for all investigated analytes  
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Figure 4.4: α diagrams 
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When looking at the results of Table 4.2 and Figure 4.4, respectively, one can see evident 
differences in α values and, therefore, in separation abilities of the single SOs. CSP 1 showed 
best overall performance of all tested CSPs. This concept of a weak anion exchange and an 
achiral cation exchanger site was investigated in previous studies in our group when tests on a 
Tau-QN CSP showed promising results.33  
A more specific discussion comparing pseudoenantiomeric CSPs Tau-QD and Tau-QN will 
be made up on the following pages.  CSP 1 can also be seen in direct competition to CSP 6 in 
terms of comparing the achiral and chiral sulfonic acid side chain, respectively. Zwitterionic 
selectors with chiral sulfonic acid side chains have been recently tested and showed so far the 
best enantioselectivity values. 33 Consequently, there were high expectations in improving 
selectivitiy and, hence, resolution when designing and synthesizing CSP 6 – but without 
satisfying results. Selectivity factors are lower than for Tau-QD throughout all groups of 
analytes – acidic, zwitterionic and basic ones. This can be due to the fact that with L-CSAD-
DH-QN an unfavorable SO configuration was chosen (when fusing chiral cysteic acid and a 
quinine/quinidine motif four diastereomeric SOs can be synthesized).  An interesting point is 
that retention factors were generally higher for CSP 6 than for CSP 1 – another argument that 
high retention factors do not at all imply high stereoselectivity coefficients. 
CSP 2 also shows lower α values than CSP 1.  It seems that an additional acidic functionality 
hampers molecular recognition and, therefore, decreases enantioselectivity.  
When testing the analyte set on Tau-Quinc (CSP 5) almost no enantioseparations were 
observed. Only partial separation for two analytes was obtained. The reason for this obviously 
lies in the absence of π – π interactions between selector and selectand due to the missing 
quinoline moiety in CSP 5. Furthermore, separation for non aromatic compounds could not 
be obtained either. Probably, this example confirms the theory that molecular recognition (and 
therefore enantiomer separation) is not only a consequence of ionic interactions, hydrogen 
bonding and π – π interactions, but also of steric interactions. In the presence of a quinoline 
moiety a binding pocket can be made up by quinuclidine and quinidine which is closed by the 
carbamate modification. It seems that this kind of binding pocket is another essential part for 
successful enantioseparation.  
This theory is confirmed by exceptional selectivity (and retention as well) of some CSPs 
towards specific analytes. When looking at Table 4.2 α values of DNB-protected amino acids 
(especially DNB-Phe), Tryptophane, dipeptides and Mefloquine are striking. The stronger 
binding enantiomers of these analytes are obviously fitting better into the binding pocket 
provided by the zwitterionic SO.  
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4.4.3 Plate number N    
 
Generally, N values provide information about column performance. In context with chiral 
stationary phases N is correlated to selector coverage and especially to packing quality. All of 
the columns have been packed in house which may result in small individual differences.  
In Table 4.3 N values for all separated analytes are shown.  
 
 
  N Values / m   
  Tau-QD  L-CSA-QN Tau-Quinc 
L-CSAD-
DH-QN 
  CSP 1 CSP 2 CSP 5 CSP 6 
Selector Loadings 
[µmol g-1] 210 240 290 260 
          
Fmoc-Phe  13020 7260 0 16313 
Z-Phe 16413 0 0 34847 
DNP-Phe 16607 0 0 33687 
DNB-Phe 19193 13333 0 32853 
Ac-Trp 24133 10120 0 15807 
DNB-Glu 12193 5867 0 6100 
DNB-Asp 8160 3020 0 9640 
Fmoc-Ser 14693 9880 0 27053 
          
          
Phe 0 0 0 0 
beta-Phe 14967 0 0 0 
alpha-Me-Phe 21253 0 0 0 
Trp 9773 1187 3717 15400 
alpha-Me-Trp 20367 2307 5766 19127 
1-Me-Trp 18567 0 0 0 
alpha-Me-DOPA 17873 4067 0 20020 
Pro 14593 0 0 0 
alpha-Me-Pro 15533 0 0 0 
Azetidinic Acid 9653 0 0 23813 
Nipecotic Acid 8400 9327 0 15533 
Pipecolic Acid 0 0 0 0 
Cysteic Acid 0 0 0 15147 
Dimethyltaurine 0 0 0 0 
Met 0 0 0 0 
Leu 0 0 0 0 
tBu-Leu 0 0 0 0 
Ser 0 0 0 0 
Thr 0 0 0 0 
Cys 0 0 0 24187 
Ala-Ala 8620 2947 0 0 
Ala-Val 16133 6647 0 0 
Leu-Leu 18940 5893 0 15133 
Pro-Phe 17147 7160 0 22087 
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Mefloquine 4053 4307 0 5067 
Oxazepam 0 0 0 0 
Clenbuterol 15027 15127 0 0 
Noscapine 0 0 0 0 
Labetalol 6493 2033 0 0 
          
 
 
Table 4.3: N values for all investigated analytes 
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Figure 4.5: N diagrams 
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First of all, one has to consider that N values were calculated by the original software 
program. If only partial separation was achieved, integration provided a vertical line between 
the two peaks. Therefore, the integrated peaks are smaller and calculated peak numbers are 
higher than they actually would be.  
Although N values can just roughly be compared with each other, some characteristics have 
become clear. Highest N values were obtained for L-CSAD-DH-QN (CSP 6). This means if 
separation took place the best peak shape could be achieved. Performance of Tau-QD (CSP1) 
was almost as good as CSP 6 obtaining slightly lower N values.  Column performance of 
CSP 2 is roughly half as good as performances of CSP 1 and CSP 6, respectively.  
No meaningful statement can be issued for CSP 5, because partial separation was achieved 
only for two analytes.  
 
 
4.4.4 Resolution RS    
 
The RS value is doubtlessly the most significant criteria when looking at chromatographic 
peak separation. In contrast to selectivity α resolution RS is a more practical tool for 
optimizing an appropriate stationary and mobile phase.   
Resolution combines selectivity α, terms of peak shape (plate number N) and SO-SA binding 
strength (retention factor k).  
Baseline separation typically requires RS values higher than 1,5. Values above 2,0 suggest 
changing the chromatographic system to avoid unnecessarily long retention times (regarding 
analytical questions). On the contrary, in preparative chromatography high resolution values 
are desired because they allow higher sample loadings.   
Table 4.4 depicts RS values for the chosen set of analytes.  
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    Rs Values     
  Tau-QD  L-CSA-QN Tau-Quinc 
L-CSAD-
DH-QN 
  CSP 1 CSP 2 CSP 5 CSP 6 
          
Fmoc-Phe  1,31 0,64 0 1,24 
Z-Phe 0,49 0 0 0,79 
DNP-Phe 2,66 0 0 0,80 
DNB-Phe 12,25 5,43 0 9,57 
Ac-Trp 5,03 2,98 0 2,04 
DNB-Glu 6,81 3,34 0 3,92 
DNB-Asp 4,48 0,63 0 1,89 
Fmoc-Ser 2,02 1,16 0 1,81 
          
          
Phe 0 0 0 0 
beta-Phe 0,62 0 0 0 
alpha-Me-Phe 0,95 0 0 0 
Trp 3,29 0,31 0,25 2,64 
alpha-Me-Trp 6,18 1,96 0,45 2,05 
1-Me-Trp 1,18 0 0 0 
alpha-Me-DOPA 1,78 0,56 0 0,27 
Pro 0,45 0 0 0 
alpha-Me-Pro 0,70 0 0 0 
Azetidinic Acid 0,58 0 0 0,93 
Nipecotic Acid 0,94 0,38 0 0,49 
Pipecolic Acid 0 0 0 0 
Cysteic Acid 0 0 0 0,43 
Dimethyltaurine 0 0 0 0 
Met 0 0 0 0 
Leu 0 0 0 0 
tBu-Leu 0 0 0 0 
Ser 0 0 0 0 
Thr 0 0 0 0 
Cys 0 /// 0 0,77 
Ala-Ala 0,52 0,65 0 0 
Ala-Val 2,34 1,24 0 0 
Leu-Leu 5,38 1,01 0 1,03 
Pro-Phe 8,98 2,32 0 2,02 
          
          
Mefloquine 2,76 3,73 0 0,33 
Oxazepam 0 0 0 0 
Clenbuterol 0,23 1,02 0 0 
Noscapine 0 0 0 0 
Labetalol 0,44 0,57 0 0 
          
 
 
 
Table 4.4 
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Figure 4.6: Rs Values  
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Figure 4.7: Separation of zwitterionic and acidic analytes on Tau-QD (CSP1)   
 (λ=254 nm, t0=1,51 min) 
 
 
              
 
 
Figure 4.8: Separation of mefloquine on Tau-QD and L-CSA-QN (CSP2) 
 (λ=254 nm, t0=1,51 min) 
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Tau-QD (CSP 1) shows best overall performance which is a logical consequence of high 
selectivity values and plate numbers. L-CSAD-DH-QN (CSP 6) comes in second followed by 
L-CSA-QN (CSP 2). However, interesting aspects can be found when looking more detailed 
at single analytes.  
First of all it has to be pointed at the extraordinary RS values for separation of DNB-Phe. The 
combination of an electron-rich and an electron poor aromatic moiety together with a sulfonic 
acid group results in strong retention and high RS values as well. DNB-Phe seems to ideally 
fit into the selector’s binding pocket. The importance of this steric interactions is also fortified 
by comparison of DNB-Glu and DNB-Asp. N-protected glutamic acid differs from DNB-Asp 
in only one additional methylen group but achieves by far better resolution values. Some of 
the free amino acids could also be well separated – predominantly tryptophane and its α–
methylated derivative. On the other hand, for amino acids containing also aromatic groups 
like phenylalanine, tyrosine (it was tested although not listed here) and α-Me-DOPA no 
separation at all or partial separation only was achieved.  
Nonaromatic, cyclic amino acids were also subject to investigation. Partial separation could 
be obtained (without recognizing any clear trends between the cyclic homologues), in contrast 
to their acyclic aliphatic counterparts where no separation took place at all. Astonishingly, no 
separation was achieved for dimethyltaurine (a derivative of taurine which is an essential 
moiety of CSP 1, 5, and 6) while cysteic acid was at least partially separated on CSP 6.  
All four dipeptides were separated on CSP 1 and 2 whereas the single amino acid e.g. leucine 
was not resolved in its enantiomers.    
Anti malarial drug mefloquine achieved extraordinary high RS values on CSP 1 and CSP 2. 
Similar to DNB-Phe this analyte enables π-π stacking between electron rich and electron poor 
aromatic moieties. Overall, CSP 2 performed best in separating chiral bases which can be 
reduced to its additional carboxylic functionality increasing ionic interaction between SO and 
the amine analytes.  
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4.5  Tau-QN versus Tau-QD 
 
After the general comparison part in the previous chapter the focus is now set on a direct 
comparison between single CSPs to underline specific characteristics of the synthesized 
CSPs.  
The Taurine-Quinine selector (Tau-QN) was previously prepared and investigated by our 
group and is the pseudoenantiomeric analog to Tau-QD (CSP 1).33 The chromatographic 
comparison between Tau-QN and Tau-QD can be considered as a fundamental part of the 
presented thesis as it offers valuable clues to the pseudoenantiomeric behaviour of both 
selectors. So far experiments have shown that elution order is switching from one enantiomer 
to the other when changing from a quinine-based- to the pseudoenantiomeric quinidine-based 
CSP (and vice versa).  
The coherences between elution orders and enantioselective interactions in the field of 
QN/QD anion exchanger CSPs have been thouroghly studied by our group and are well 
understood.36 Now it has to be evaluated if the pseudoenantiomeric behaviour is preserved in 
the zwitterionic CSP motif. In Table 4.5 the chromatographic results are shown – capital 
letters L and D are indicating which enantiomer was eluting first.  
 
Comparison of Tau-QN versus Tau-QD  
  Tau-QN Tau-QD (CSP 1) 
  EO k2 α  Rs EO k2 α  Rs 
                  
Fmoc-Phe D-L 0,75 1,47 1,71 L-D 0,58 1,55 1,31 
Z-Phe  D-L 0,36 1,25 0,78 L-D 0,25 1,46 0,49 
DNP-Phe  L-D 0,62 1,18 0,99 D-L 0,68 1,78 2,66 
DNB-Phe  D-L 3,88 10,10 11,81 L-D 2,42 9,89 12,25 
Ac-Trp D-L 1,15 2,40 4,28 L-D 0,83 3,41 5,03 
DNB-Glu n.d. 3,67 3,46 7,36 n.d. 2,25 3,82 6,81 
DNB-Asp n.d. 4,64 1,17 1,21 n.d. 5,40 1,90 4,48 
Fmoc -Ser  D-L 0,83 1,52 1,80 L-D 0,62 1,75 2,02 
                  
                  
Phe   0,79 1,00 0   0,43 1,00 0 
beta-Phe  1,23 1,00 0 L-D 0,97 1,11 0,62 
alpha-Me-Phe n.d. 0,58 1,26 1,61 n.d. 0,44 1,26 0,95 
Trp  D-L 1,72 1,60 4,11 L-D 1,44 1,82 3,29 
alpha-Me-Trp  n.d. 3,08 2,46 5,34 n.d. 1,80 2,41 6,18 
1-Me Trp  n.d. 1,36 1,33 1,88 n.d. 0,98 1,20 1,18 
alpha-Me-DOPA D-L 1,18 1,44 2,82 L-D 0,79 1,41 1,78 
ProPhe  n.d. 3,69 2,06 5,28 n.d. 2,81 3,21 8,98 
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Mefloquine n.d. 3,83 1,26 1,60 n.d. 2,64 1,88 2,76 
Oxazepam   0,54 1,00 0   0,40 1,00 0 
Clenbuterol  2,40 1,00 0 n.d. 1,50 1,03 0,23 
Noscapine  0,41 1,00 0   0,32 1,00 0 
Labetalol  4,72 1,00 0 n.d. 2,90 1,07 0,44 
                  
 
Table 4.5  
 
A switch of elution orders is obtained for every tested analyte, which confirms that the 
pseudoenantiomeric properties are maintained in the concept of zwitterionic CSPs. This 
experiment also certifies that the quinine/quinidine motif is the driving force for 
enantioselective recognition in the zwitterionic selector and the steric influence by the acidic 
cation exchange moieties is limited.   
 
Figure 4.9 depicts resolution- and retention values for both Tau-QN and Tau-QD CSP.  
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Figure 4.9  
 
 
Although Tau-QN and Tau-QD CSPs possess almost the same SO coverage (205 µmol g-1 and 
210 µmol g-1, respectively) and have identical ionic interaction sites (as main attractive force), 
their retention factors are differing. Also by interpretation of resolution values one can see 
significant differences in stereoselectivity, which can only be reduced to the fact that 
configuration of the alkaloid scaffold plays a very important role in stereodiscrimination. 
The arguments of obtaining different chromatographic values in combination with a change in 
elution orders between Tau-QN and Tau-QD clearly describe pseudoenantiomeric behaviour 
and impressively confirm that the pseudoenantiomeric properties are preserved in zwitterionic 
CSPs.  
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Figure 4.10: Switch of elution orders between Tau-QD and Tau-QN  
 (λ=254 nm, t0=1,51 min, enantioenriched samples) 
 
In Table 4.6 elution orders of the remaining zwitterionic CSPs are shown. CSP 2 and CSP 6 
employ the quinine motif and provide the same elution orders, which is in contrast to 
quinidine based CSP 1 where elution order is inverted.  
 
  Elution Order   
  Tau-QD  L-CSA-QN Tau-Quinc 
L-CSAD-
DH-QN 
  CSP 1 CSP 2 CSP 5 CSP 6 
          
Fmoc-Phe  L D /// D 
Z-Phe L /// /// D 
DNP-Phe D /// /// L 
DNB-Phe L D /// D 
Ac-Trp L D /// D 
Fmoc-Ser L D /// D 
          
          
beta-Phe L /// /// /// 
Trp L D /// D 
alpha-Me-DOPA L D /// D 
          
 
Table 4.6 
Fmoc-Phe on Tau-QD  
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4.6 Tau-QN versus Tau-N-Methyl-QN 
 
Tau-N-Methyl-QN (CSP 4) was mainly designed and synthesized for comparison to the Tau-
QN CSP. By comparison CSP 4 to Tau-QN a strong anion exchange (SAX) motif is opposed 
to the weak one of Tau-QN. The motivation for designing this selector was to generate a 
SAX-complement to the meanwhile well established strong cation exchange motif.  
CSPs bearing a strong cation exchange binding site (e.g. Tau-QD) generally provide better 
enantioseparations than selectors comprising weak cation exchangers (e.g. CSPs with a 
carboxylic functionality). This fact has been shown by our group when carrying out 
chromatographic studies on a Tau-QN (a sulfonic acid carbamoyl-QN) and a carboxylic acid 
carbamoyl-QN.  
 
Therefore, the concept of a strong exchanger was introduced on the alkaloid motif via 
methylation of the quinuclidine nitrogen. In conventional QN/QD-AX CSPs the tertiary 
amine moiety in the quinuclidine system is positively charged due to protonation. When 
introducing a methyl group the tertiary amine is transformed into a permanent quaternary 
ammonium ion becoming a strong anion exchanger. However, hydrogen bond arranged ionic 
interactions – as they occur in the weak anion exchange motif – are ceased to exist in the 
quaternary ammonium ion.  
 
As mentioned in the synthetic chapter, CSP 4 is of only low selector coverage of 105 µmol g-1 
in contrast to the Tau-QN CSP with a SO loading of 205 µmol g-1. This matter didn`t allow 
comparisons of retention times and, thus, terms of selectivity and resolution were discussed 
only as they are not that much influenced by SO coverage. 
For chromatographic investigations the set of analytes was slightly modified including some 
new analytes which are depicted in Figure 4.11. 
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Figure 4.11   
 
 
In Table 4.7 selectivity and resolution values for Tau-N-Methyl-QN and Tau-QN are 
depicted. 
 
Comparison of Tau-QN versus Tau-N-Methyl-QN 
       Tau-QN      Tau-N-Methyl-QN  
  α  Rs α  Rs 
          
Fmoc-Phe 1,47 1,71 1,22 1,21 
Z-Phe  1,25 0,78 1,22 1,31 
DNP-Phe  1,18 0,99 1,26 2,31 
DNB-Phe  10,10 11,81 1,93 5,25 
Ac-Trp 2,40 4,28 1,48 2,45 
DNB-Glu 3,46 7,36 1,39 1,22 
DNB-Asp 1,17 1,21 1,06 0,36 
Fmoc -Ser  1,52 1,80 1,34 2,03 
Dibenzoyl tartaric acid 1,36 1,68 1,16 0,63 
Dichlorprop 1,73 0,71 1,30 0,98 
Ibuprofen 1,00 0 1,00 0 
Suprofen 1,19 0,61 1,04 0,31 
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Phe  1,00 0 1,00 0 
beta-Phe 1,00 0 1,00 0 
alpha-Me-Phe 1,26 1,61 1,00 0 
Trp  1,60 4,11 1,09 0,39 
alpha-Me-Trp  2,46 5,34 1,64 1,87 
1-Me Trp  1,33 1,88 1,00 0 
alpha-Me-DOPA 1,44 2,82 1,33 0,71 
ProPhe  2,06 5,28 1,51 2,39 
          
          
Mefloquine 1,26 1,60 1,00 0 
Oxazepam  1,00 0 1,00 0 
Clenbuterol 1,00 0 1,00 0 
Noscapine 1,00 0 1,00 0 
Labetalol 1,00 0 1,00 0 
          
 
Table 4.7 
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Figure 4.12: Selectivity values for Tau-QN and Tau-N-Methyl-QN 
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Figure 4.13: Resolution values for Tau-QN and Tau-N-Methyl-QN 
 
 
The obtained results clearly show the negative influence of a strong anion exchange binding 
site on enantioseparation of a zwitterionic CSP. On CSP 4 both selectivity and resolution 
values for all classes of analytes (acidic, basic and zwitterionic) are lower compared to Tau-
QN bearing the weak anion exchange motif. Another striking fact is that no enantioseparation 
for chiral amines was obtained on Tau-N-Methyl-QN. Even Mefloquine was not separated 
which normally led to extraordinary high resolution values on Tau-QD, Tau-QN or L-CSA-
QN. This can be attributed to the fact that the stronger repulsive interactions between the 
amine analyte and the SAX moiety badly affect the enantiomer recognition process.  
On the other hand, a strong anion exchange binding site should result in higher retention for 
acidic analytes. However, this theory could not be empirically confirmed due to the strongly 
differing SO coverage. 
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4.7 Tau-QN versus L-CSAD-DH-QN  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: Comparison of Tau-QN and L-CSAD-DH-QN (CSP 6)  
 
 
Within this chapter two selectors are related to each other which are mainly differing in their 
connectivity to their support material. L-CSAD-DH-QN (CSP 6) is bound to the silica on the 
carbamate site of the selector and, therefore, seen as a more volatile SO compared to the other 
herein presented CSPs. This selector is supposed to have better accessibility for ionic 
interactions due to a greater distance to the support material. The additional stereogenic center 
on the cation exchange site was hoped to positively affect enantioseparation, too.  
In contrary to the general comparison chapter, CSP 6 is now set in contrast to its Tau-QN 
equivalent in stead of the pseudoenantiomeric Tau-QD CSP.    
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Comparison of Tau-QN versus L-CSAD-DH-QN  
  Tau-QN L-CSAD-DH-QN (CSP 6) 
  k2 α  Rs k2 α  Rs 
              
Fmoc-Phe 0,75 1,47 1,71 3,20 1,13 1,24 
Z-Phe  0,36 1,25 0,78 2,28 1,07 0,79 
DNP-Phe  0,62 1,18 0,99 3,33 1,06 0,80 
DNB-Phe  3,88 10,10 11,81 4,63 2,06 9,57 
Ac-Trp 1,15 2,40 4,28 3,26 1,21 2,04 
DNB-Glu 3,67 3,46 7,36 17,15 1,74 3,92 
DNB-Asp 4,64 1,17 1,21 20,26 1,23 1,89 
Fmoc -Ser  0,83 1,52 1,80 3,51 1,15 1,81 
              
              
Phe  0,79 1,00 0 0,98 1,00 0 
beta-Phe 1,23 1,00 0 1,09 1,00 0 
alpha-Me-Phe 0,58 1,26 1,61 0,88 1,00 0 
Trp  1,72 1,60 4,11 1,67 1,49 2,64 
a-Me-Trp  3,08 2,46 5,34 1,79 1,28 2,05 
1-Me Trp  1,36 1,33 1,88 1,46 1,00 0 
a-Me-DOPA 1,18 1,44 2,82 1,28 1,03 0,27 
ProPhe  3,69 2,06 5,28 2,39 1,23 2,02 
              
              
Mefloquine 3,83 1,26 1,60 1,32 1,05 0,33 
Oxazepam  0,54 1,00 0 0,02 1,00 0 
Clenbuterol 2,40 1,00 0 0,89 1,00 0 
Noscapine 0,41 1,00 0 0,70 1,00 0 
Labetalol 4,72 1,00 0 1,73 1,00 0 
              
 
Table 4.8 
 
 
Results in Table 4.8 are very similar to those in the general comparison part which means that 
capacity factors of CSP 6 are extraordinary high for acidic analytes and lower for basic 
analytes in comparison to Tau-QN CSP (outlined in Figure 4.15). This is an unexpected 
result because ion exchange binding sites (as primary interaction force) and the alkaloid 
scaffold are identical for both selectors. Consequently, the significant differences in retention 
times must rely on a spatially different molecular recognition process. It is not yet cleared in 
what way the newly generated steric bulk (on the cation exchange site) affects 
stereoselectivity. Due to lack of time other diastereomeric forms of this SO (e.g. D-CSAD-
DH-QN or L-CSAD-DH-QD) could not have been synthesized whose configurations are 
probably better appropriated to stereodiscrimination.  
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What needs also to be underlined is that high retention times do not automatically imply high 
enantioseparation values as for CSP 6 lower selectivity and resolution values are obtained for 
all classes of analytes than for Tau-QN. 
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Figure 4.15: k2 values    
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4.8 Quinu-QD versus QD-AX   
 
This comparison could be interpreted as a challenge between single and double anion 
exchange CSPs. Quinu-QD (a quinuclidine carbamoyl QD CSP) comprises two basic anion 
exchange moieties. Like the QD-AX CSP it was mainly designed for separation of chiral 
acidic analytes like N-protected amino acids and profenes. Additionally, bisacidic analytes 
were subject to investigation to study molecular recognition processes of bisbasic – bisacidic 
selector – selectand interactions. Figure 4.16 depicts both slectors Quinu-QD (CSP 3) and the 
well established standard QD-AX selector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 
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Results of chromatographic investigations are shown in Table 4.9 and Figure 4.17. Before 
some additional information has to be given: Both CSP 4 and QD-AX CSP were tested on 
non target molecules as there are chiral bases and zwitterionic analytes. Most basic analytes 
injected on both CSPs eluted around the void volume or even before the void volume. This 
behaviour can be attributed to slight repulsion instead of attractive molecular interaction. 
Furthermore, no enantioseparation was obtained for zwitterionic analytes.  
 
 
  Quinu-QD (CSP 3) 
  EO k1 k2 α Rs 
            
Fmoc-Phe  L-D 12,39 13,36 1,08 1,44 
Z-Phe  L-D 7,89 8,28 1,05 0,85 
DNP-Phe    14,39 14,39 1,00 0 
DNB-Phe  L-D 7,90 15,30 1,94 13,15 
Ac-Trp L-D 7,74 8,52 1,10 1,64 
DNB-Glu n.d.  110,89 156,76 1,41 5,09 
DNB-Asp   /// /// /// /// 
Fmoc -Ser  L-D 10,30 10,97 1,06 1,20 
Dibenzoyl tartaric acid   78,36 78,36 1,00 0 
Dichlorprop n.d.  4,97 5,52 1,11 2,00 
Ibuprofen   3,05 3,05 1,00 0 
Suprofen   5,48 5,48 1,00 0 
            
 
 
  QD-AX CSP 
  EO k1 k2 α Rs 
            
Fmoc-Phe  L-D 3,06 5,11 1,67 6,18 
Z-Phe  L-D 2,01 2,67 1,33 3,29 
DNP-Phe  D-L 4,47 5,41 1,21 2,93 
DNB-Phe  L-D 2,19 22,27 10,19 22,22 
Ac-Trp L-D 2,02 3,29 1,63 4,28 
DNB-Glu n.d. 14,49 65,81 4,54 12,32 
DNB-Asp n.d. 60,03 109,92 1,83 4,51 
Fmoc -Ser  L-D 2,67 4,29 1,60 5,56 
Dibenzoyl tartaric acid n.d. 1,89 2,03 1,07 0,76 
Dichlorprop n.d. 1,77 2,49 1,40 2,69 
Ibuprofen n.d. 0,87 1,01 1,17 0,86 
Suprofen n.d. 2,44 2,75 1,13 1,45 
            
 
Table 4.9  
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Figure 4.17  
 
Quinu-QD (CSP 3) obtained extraordinary high capacity factors, in particular for the bisacidic 
analytes DNB-Glu, DNB-Asp and dibenzoyl tartaric acid. For example, the second 
enantiomer of DNB-Glu eluted after 238 min (!). The non separated peak of dibenzoyl tartaric 
acid came at 119 min similar to DNB-Asp, which showed very strong peak tailing and, 
therefore, chromatographic parameters could not be determined. Chromatograms of these 
analytes are shown in Figure 4.18 and 4.19. 
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Generally, Quinu-QD obtained signifcantly higher capacity factors also for monoacidic 
analytes like N-protected amino acids. This behaviour can be attributed to the bisbasic 
properties of Quinu-QD which means that this CSP has more ionic interaction sites per 
surface unit and, thus, builds up stronger ionic interactions with acidic analytes in contrast to 
the monobasic standard QD-AX CSP.  
Detailed comparison of resolution values is not meaningful because the Quinu-QD selector 
was immobilized in its diastereomeric form (see synthetic chapter 3.3) which probably 
hampers stereodiscrimination of analytes.  
 
 
 
Figure 4.18: Separation of DNB-Glu   
 (λ=254 nm, t0=1,51 min) 
 
 
 
Figure 4.19: Separation of Z-Phe    
 (λ=230 nm, t0=1,51 min, enantioenriched samples) 
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4.9 Conclusion and Outlook   
 
Novel ion exchange chiral stationary phases have been designed, synthesized and 
chromatographically evaluated. Based on the concept of recently – in house - prepared 
zwitterionic CSPs the main focus was on development and preparation of carbamate- and 
cinchona-modified zwitterionic chiral stationary phases.  
In addition to the zwitterionic CSPs a bisbasic quinidine selector was prepared for comparison 
to the standard quinidine anion exchange CSP. Six zwitterionic CSPs and two anion 
exchanger type chiral stationary phases were chromatographically evaluated whereas chiral 
acids, chiral bases and chiral amino acids had been used as analytes. Successful 
enantioseparations for all classes of analytes again confirmed that the ZWIX motif is 
promising and working.  
Chromatographic key parameters of retention, selectivity and resolution were compared to 
each other for all synthesized CSPs to elucidate general trends and to enlighten the complex 
selector – selectand molecular recognition process.  
Remarkable differences in the obtained chromatographic data amongst the evaluated CSPs are 
giving a good reason to further structural modifications of zwitterionic chiral stationary 
phases. Firstly, to learn more about stereochemically driven molecular interactions and, 
secondly, to support enhancement of the selectors` separation abilities. For example efforts on 
the non realized DACH-QD selector could be made to use it as a building block for a more 
complex zwitterionic selector.  
What could not be realized in this work were experiments to optimize the mobile phase in 
terms of retention and enantioselectivity parameters. No doubt, tuning of mobile phase 
parameters (especially choice of the bulk solvent and concentration of co- and counterions) 
will certainly ameliorate enantioseparation in some special cases.  
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5 Experimental     
 
Materials & Methods: 
 
1H-NMR and 13C-NMR were recorded at room temperature with a Bruker DRX400 
spectrometer. The spectra were recorded in CDCl3, CDOD3 and DMSO-d6 and the solvent 
signals were used as reference. The raw data were processed with SpinWorks Version 2.5.5. 
software.  
Analytical thin-layer chromatography (TLC) was performed on Kieselgel 60 F254 plates from 
Merck (Darmstadt, Germany). Column chromatography was performed on silica gel 60 
(0.040-0.063mm) (Merck). ESI-mass spectra were recorded on a PE Sciex API 365 
spectrometer.  
MeOH (gradient grade quality, Merck), n-hexane (gradient grade quality, Roth, Karlsruhe, 
Germany), n-heptane (gradient grade quality, Roth), CH2Cl2 (p.a. puriss quality, Fluka, 
Vienna, Austria), diethylether (Et2O, puriss. quality), DMF (purum >99%, anhydrous) and 
toluene (>99%) were used as solvents. For column chromatography methanol and 
dichloromethane were used in technical grade quality. For using dried dichloromethane it was 
distilled over CaH2. All chemical reactions were carried out under nitrogen atmosphere. 
Generally, all the CSPs were prepared by immobilization of the chiral selectors onto 3-
mercaptopropyl-modified, endcapped silica gel via radical addition with AIBN (about 40 mg 
AIBN per mmol selector were used). Thiol-activated silica was initially prepared from 
Daisogel 120-5 (pore size 120 Ǻ, particle size 5 μm) from Daiso (Osaka, Japan) and was 
available from stock. The selector loadings were calculated based on the nitrogen content (w-
% N). Analysis of the filtrate by ESI-MS confirmed selector integrity during immobilization 
conditions while unreacted selector could be recovered from the filtrate by simple flash 
chromatography if appropriate. Each CSP was slurry packed in house into stainless steel 
columns (each 150x4.0 mm I.D.). 
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9-O-(4-nitrophenyloxycarbonyl)quinidine hydrochloride  (2, activated quinidine 
ester hydrochloride)  
8.00 g of quinidine as a free base (24.7 mmol) were dissolved in 300 ml of toluene followed 
by azeotropic distillation (removal of 1/3 of the solvent) using a Dean-Stark trap. After 
cooling to room temperature (r.t.) 5.04 g (25.0 mmol) of 4-nitrophenyl chloroformate were 
added as a solid. The mixture was stirred at r.t. over night. Hydrochloride 2 was formed as a 
yellowish precipitate. The solid was filtrated off, washed in n-hexane (3x50 ml) and stored in 
a nitrogen atmosphere to avoid hydrolysis (almost quantitative yield).  
MS (ESI, positive): 490.2 [M+H]+, 383.3 [methoxycarbonate of 2]+. 
 
 
N-[[[(8R,9S)-6'-methoxycinchonan-9-yl]oxy]carbonyl]-taurine (3)  
Finely grounded taurine (0.50 g, 4.0 mmol) was suspended in dried CH2Cl2. While stirring the 
suspension BSA (3.0 ml, 12.0 mmol) was added with a Hamilton syringe via septum followed 
by refluxing for 24 h until the solution became clear. After cooling to r.t. 2.10 g (4.0 mmol) of 
quinidine activated ester hydrochloride 2 were added and stirring continued for 24 h. The 
reaction was quenched with MeOH. The turbid mixture was stirred for another 30 min and 
was then transferred directly onto a silica flash column. Purification by gradient 
chromatography (CH2Cl2 : MeOH 15:1 – 3:1) yielded 1.24 g (65 %) of 3 as yellowish 
crystals.  
1H-NMR [CD3OD]: δ = 1.47 (m,1H), 1.83-2.02 (m, 2H), 2.06 (m,1H), 2.42 (m, 1H), 2.77 (m, 
1H), 3.02 (m, 2H), 3.37 (m, 1H), 3.51-3.65 (m, 5H), 3.87 (m, 1H), 4.01 (s, 3H), 5.24-5.33 (m, 
2H), 6.14 (m, 1H), 7.11 (s, 1H), 7.50-7.56 (m, 2H), 7.78 (d, 1H), 7.96 (d, 1H), 8.79 (d, 1H).   
MS (ESI, positive): 476.2 [M+H]+. 
 
 
CSP 1 (Immobilization of the chiral selector 3)  
2.62 g of silica were suspended/elutriated in 20 ml MeOH. The selector 3 (0.50 g, 1.1 mmol) 
was dissolved in 15 ml MeOH and added to the slurry. After flushing for 15 minutes with 
nitrogen AIBN (70 mg, 0.43 mmol) was added and the suspension was refluxed for 5 h. After 
immobilization the modified silica gel was collected by filtration, washed with MeOH (3x30 
ml) and CH2Cl2 (2x30 ml), dried under reduced pressure at 60°C over night and subjected to 
elemental analysis: 0.603 % N results in SO loading of  210 µmol g-1. 
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9-O-(4-nitrophenyloxycarbonyl)quinine hydrochloride  (5, activated quinine 
ester hydrochloride)  
16.00 g of quinine as a free base (49.3 mmol) were dissolved in 600 ml of toluene. Azeotropic 
distillation (ca. 1/3 of the solvent was removed) using a Dean-Stark trap. After cooling to r.t. 
10.08 g (50.0mmol) of 4-nitrophenyl chloroformate were added as a solid. The mixture was 
stirred at r.t. over night. A yellowish precipitate was formed. The solid was filtrated off, 
washed in n-hexane and stored in a nitrogen atmosphere to avoid hydrolisation (quantitative 
yield).  
MS (ESI, positive): 383.3 [methoxycarbonate of 5]+. 
 
 
N-[[[(8S,9R)-6'-methoxycinchonan-9-yl]oxy]carbonyl]-L-cysteic acid (6) 
Finely grounded L-cysteic acid (0.75 g, 4.4 mmol) was suspended in dried CH2Cl2. While 
stirring the suspension BSA (4.0 ml, 16.3 mmol) was added with a Hamilton syringe via 
septum. Refluxing for 48 h until solution became clear. After cooling to r.t. 2.10 g (4.0 mmol) 
quinine activated ester hydrochloride were added and again stirred for additional 24 h at r.t. 
The reaction was quenched with MeOH. The turbid mixture was stirred for 30 more minutes 
and transferred directly onto a flash column. Purification by chromatography 
(dichloromethane : methanol 10:1 – 1:1) yielding 1.50 g (72 %) of yellowish crystals.  
1H-NMR [CD3OD]: δ = 1.72 (m, 1H), 1.93 (m, 1H), 2.09 (m, 1H), 2.24 (m, 2H), 2.78 (m, 
1H), 3.20 (m, 1H), 3.33-3.48 (m, 3H), 3.65 (m, 1H), 3.84 (t, 2H), 4.03 (s, 3H), 4.59 (t, 1H), 
5.06 (m, 2H), 5.75 (m, 1H), 6.96 (s, 1H), 7.42-7.59 (m, 2H), 7.84 (d, 1H), 8.03 (d, 1H), 8.03 
(d, 1H), 8.78 (d, 1H). 
MS (ESI, positive): 520.3 [M+H]+. 
 
 
CSP 2  (Immobilization of the chiral selector 6)  
2.89 g of 3-mercaptopropylmethyl-silica were elutriated in 20 ml of MeOH. 0.60 g (1.2 
mmol) of selector 6 were dissolved in 15 ml of MeOH. 60 mg (0.37 mmol) of AIBN were 
taken. Elemental analysis: 0.998 % N results in SO loading of 240 µmol g-1. 
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N-[[[(8R,9S)-6'-methoxycinchonan-9-yl]oxy]carbonyl]-3-quinuclidine (7) 
First, the free base of 3-aminoquinuclidine dihydrochloride (racemic mixture) was prepared 
by reacting with equimolar amounts of KOH (methanolic solution). 0.58 g (4.6 mmol) of 3-
aminoquinuclidine were dissolved in CH2Cl2 and 2.00 g (3.8 mmol) of activated quinidine 
hydrochloride 2 were added portionwise to the turbid solution. Stirring at r.t. was maintained 
until TLC showed complete conversion of 2 (18 h) and purification by chromatography 
(CH2Cl2 : MeOH 10:1 – 1:1) yielded 0.65 g (36 %) of 7 as a yellowish solid.   
MS (ESI, positive):  477.4 [M+H]+. 
 
 
CSP 3 (Immobilization of the chiral selector 7)  
 3.00 g of 3-mercaptopropylmethyl-silica were elutriated in 25 ml of MeOH. 0.58 g (1.2 
mmol) of selector 7 were dissolved in 20 ml of MeOH. 60 mg (0.37 mmol) of AIBN were 
used. Elemental analysis: 1.22 % N results in SO loading of 218 µmol g-1. 
 
 
N-[[[(8S,9R)-6'-methoxycinchonan-9-yl]oxy]carbonyl]-taurine (8) 
Finely grounded taurine (0.50 g, 4.0 mmol) was suspended in dried CH2Cl2. While stirring the 
suspension BSA (3.0 ml, 12.0 mmol) was added with a Hamilton syringe. Refluxing over 
night until solution became clear. After cooling to r.t. 2.10 g (4.0 mmol) activated quinine 
ester hydrochloride 5 were added and stirred for 48 h. The reaction was quenched with MeOH 
and the turbid mixture stirred for 1 more h. It was directly transferred onto a flash column and 
purified by chromatography (dichloromethane : methanol 15:1 – 1:1) yielding 0.88 g (47 %) 
of a pale yellow solid.  
1H-NMR [CD3OD]: δ = 1.79 (m, 1H), 2.00 (m, 1H), 2.15 (m, 1H), 2.28 (m, 2H), 2.84 (m, 
1H), 3.00 (m, 2H), 3.34 (m, 2H), 3.54 (t, 2H), 3.68 (t, 1H), 3.84 (m, 2H), 4.13 (s, 3H), 5.10 
(m, 2H), 5.78 (m, 1H), 7.07 (s, 1H), 7.78 (m, 2H), 8.07 (d, 1H), 8.15 (d, 1H), 8.95 (d, 1H). 
MS (ESI, positive): 476.2 [M+H]+. 
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N-[[[(8S,9R)-1-N-methyl-6'-methoxycinchonan-9-yl]oxy]carbonyl]-taurine (9) 
First taurine quinine 8 was converted into its potassium salt by addition of equimolar amounts 
of KOH (methanolic solution). 0.89 g (1.7 mmol) of the potassium salt were dissolved in 
DMF. While stirring 0.54 ml (8.7 mmol) of iodomethane were added dropwise with a 
Hamilton syringe via septum. Stirring at r.t. for 60 h. The solvent and excess iodomethane 
were removed using a rotary evaporator and the residue was resolved in 15 ml MeOH. By 
addition of Et2O a yellow precipitate was formed which was filtrated off and washed in 
diethylether yielding a yellow powder. 
The raw product was purified by preparative RP-HPLC (Phenomenex Gemini C18 column, 
100x21.20 mm, 10µm, MP: H2O/MeOH 50/50  50mM NH4Ac, flow rate 4-6 ml/min, samples 
dissolved in DMSO) yielding 9 as an auburn oil (0.80 g, 70%).  
MS (ESI, positive): 476.2 [educt+H]+, 490.2 [M]+ 
 
 
CSP 4  (Immobilization of the chiral selector 9)  
 2.30 g of 3-mercaptopropylmethyl-silica were elutriated in 20 ml of MeOH. 0.51 g (1.0 
mmol) of selector were dissolved in 15 ml of MeOH. 45 mg (0.27 mmol) of AIBN were used. 
Elemental analysis: 0.442 % N results in SO loading of 105 µmol g-1 
 
 
4-nitrophenyl (8-vinylquinuclidin-2-yl)methyl carbonate (11, activated 
quincorine ester hydrochloride)  
Azeotropic distillation of toluene using a Dean-Stark trap, then 1.00 g (6.0mmol) of 
quincorine was added dropwise with a Hamilton Syringe. While stirring the solution 1.26 g 
(6.3 mmol) of 4-nitrophenyl chloroformate was added as a solid. The mixture was stirred at 
r.t. over night. The precipitate was filtrated off, washed in n-heptane and stored in a nitrogen 
atmosphere to avoid hydrolisation (quantitative yield).  
MS (ESI, positive): 226.3 [methoxycarbonate of 11]+. 
 
 
 
 
 
 
 79
2-(((8-vinylquinuclidin-2-yl)methoxy)carbonylamino)ethanesulfonic acid  (12) 
Finely grounded taurine (0.31 g, 2.5 mmol) was suspended in dried dichloromethane. While 
stirring the suspension BSA (1.9 ml, 7.5 mmol) was added with a Hamilton syringe. 
Refluxing over night until solution became clear. After cooling to r.t. 0.83 g (2.5 mmol) of 
activated quincorine ester hydrochloride were added and stirred for 40 h. The reaction was 
quenched with MeOH. The turbid mixture was stirred for 1 h. To remove excess 4-
nitrophenol the raw product was purified by flash column chromatography (dichloromethane : 
methanol 25:1 – 10:1). The product and byproduct acetamid coeluted at high MeOH-content 
of the eluent. Acetamide was removed from the product by trituration in acetone to afford 
solid 12 (almost quantitative yield).  
1H-NMR [CD3OD]: δ = 1.36 (m, 1H), 1.97 (m, 2H), 2.07 (m, 1H), 2.18 (m,1H), 2.89 (m,2H), 
2.97 (m, 1H), 3.24 (m, 2H), 3.60 (m, 4H), 3.77 (m, 1H), 4.20 m, 1H), 4.32 (m, 1H), 5.23 (m, 
2H), 5.96 (m, 1H). 
MS (ESI, positive):  319.4 [M+H]+. 
 
 
CSP 5  (Immobilization of the chiral selector 12)  
2.20 g of 3-mercaptopropylmethyl-silica were elutriated in 25 ml of MeOH. 0.30 g (0.9 
mmol) of selector 12 were dissolved in 15 ml of MeOH. 40 mg (0.24 mmol) of AIBN were 
used. Elemental analysis: 0.817 % N results in SO loading of 290 µmol g-1 
 
 
9-O-(4-nitrophenyloxycarbonyl)dihydroquinine hydrochloride  (14, activated 
dihydroquinine ester hydrochloride)  
8.00 g of dihydroquinine as a free base (24.5 mmol) were dissolved in 300 ml of toluene. 
Azeotropic distillation (removal of 1/3 of the solvent) using a Dean-Stark trap. After cooling 
to r.t. 5.04 g (25.0 mmol) of 4-nitrophenyl chloroformate were added as a solid. The mixture 
was stirred at r.t. over night. A yellowish precipitate was formed. The solid was filtrated off, 
washed in n-hexane and stored in a nitrogen atmosphere to avoid hydrolisation (quantitative 
yield).  
MS (ESI, positive): 385.3 [methyoxycarbonate of 14]+. 
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N-[[[(8S,9R)-6'-methoxy-(10,11-dihydro-cinchonan)-9-yl]oxy]carbonyl]-L-cysteic 
acid (15) 
Finely grounded L-cysteic acid monohydrate (0.83 g, 4.4 mmol) was suspended in dried 
CH2Cl2. While stirring the suspension BSA (5.4 ml, 22.2 mmol) was added with a Hamilton 
syringe. Refluxing for 24 h until solution became clear. After cooling to r.t. 2.34 g (4.4 mmol) 
of activated dihydroquinine ester hydrochloride 14 were added and the solution was stirred for 
60 h. The reaction was quenched with MeOH. After a few minutes a viscous gum was 
formed. The supernatant was decanted off and the residue was resuspended in MeOH. The 
solvent was evaporated yielding 1.75 g (76 %) of pure product.  
1H-NMR [CD3OD]: δ = 0.83 (t, 3H), 1.32 (m, 2H), 1.74 (m, 1H), 1.85 (m, 1H), 2.09 (m, 1H), 
2.26 (m, 2H), 3.00 (m, 1H), 3.22(m, 1H), 3.40 (m, 2H), 3.63 (t, 1H), 3.81 (m, 2H), 4.09 (s, 
3H), 4.32 (m, 1H), 4.68 (m, 1H), 7.03 (s, 1H), 7.65 (m, 2H), 8.04 (d, 1H), 8.10 (d, 1H), 8.85 
(d, 1H). 
MS (ESI, positive): 520.3 [M+H]+. 
 
 
N-[[[(8S,9R)-6'-methoxy-(10,11-dihydro-cinchonan)-9-yl]oxy]carbonyl]-
allylamido-L-cysteic acid (16) 
1.37 g (2.6 mmol) of diacid 15 were dissolved in anhydrous DMF. DCC (0.54 g, 2.6 mmol) 
were added and stirring was maintained for 10 min when 0.2 ml (2.6 mmol) allylamine were 
added dropwise with a Hamilton syringe. The solution was stirred at r.t. for 70 h while 
monitoring the reaction progress via TLC. The reaction was quenched with 0.1 ml acetic acid 
and was stirried at r.t. for 1 h. before being cooled to 0°C and stirred for 3 h. 
Dicyclohexylurea precipitated and was filtrated off. The filtrate was concentrated yielding 
1.20 g (82 %) of raw product. No further purification was applied.  
1H-NMR [CD3OD]: because of educt and solvent impurities no exact peak identifications 
could be carried out. Nevertheless, the crucial peaks reflecting the allylamide moiety could be 
ascertained: δ = 5.39 (m, 2H), 5.90 (m, 1H). 
MS (ESI, negative): 520.3 [educt-H]-, 559.4 [M-H]-. 
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CSP 6 (Immobilization of the chiral selector 16)  
Because of the unknown amount of pure product all the raw product was used for selector 
immobilization. 2.20 g of 3-mercaptopropylmethyl-silica were elutriated in 20 ml of MeOH. 
1.20 g of selector were dissolved in 15 ml of MeOH using 80 mg (0.49 mmol) of AIBN. 
Elemental analysis: 1,47 % N results in SO loading of  260 µmol g-1 
 
 
N-[[[(8R,9S)-6'-methoxycinchonan-9-yl]oxy]carbonyl]-1R,2R-
diaminocyclohexane  (17) 
3.45 g (6.6 mmol) of activated quinidine ester hydrochloride 2 were suspended in CH2Cl2. To 
the stirred solution 0.90 g (7.9 mmol) of (1R,2R)-1,2-diaminocyclohexane were added in 
portions. The solution was stirred at r.t. over night. Purification by chromatography (CH2Cl2 : 
MeOH 20:1 – 3:1) yielded diamine 17 (0.76 g, 25%) as yellow crystals.  
1H-NMR [CD3OD]: δ = 1.22-1.54 (m, 5H), 1.73-1.92 (m, 5H),  1.95 (m, 1H), 2.06 (m, 1H), 
2.31 (m, 1H), 2.63 (m, 1H), 3.00 (m, 1H), 3.14 (m, 1H), 3.32-3.44 (m, 3H), 3.54 (m, 1H), 
3.66 (m, 1H), 4.04 (s, 3H), 5.50 (m, 2H), 6.22 (m, 1H), 6.94 (s, 1H), 7.42-7.58 (m, 3H), 7.97 
(d, 1H), 8.67 (d, 1H). 
MS (ESI, positive): 465.4 [M+H]+. 
 
 
Immobilization of the chiral selector 17 
5.00 g of 3-mercaptopropylmethyl-silica were elutriated in 50 ml of MeOH. 0.70 g (1.5 
mmol) of selector were dissolved in 20 ml of MeOH. 60 mg (0.37 mmol) of AIBN were used.  
According to MS-analysis selector breakdown took place after immobilization. 
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N-[[[(8S,9R)-6'-methoxycinchonan-9-yl]oxy]carbonyl]-D,L-cysteic acid (19) 
1.15 (6.8 mmol) of finely grounded cysteic acid (racemic mixture) were suspended in dried 
CH2Cl2. While stirring the suspension 6.1 ml (24.9 mmol) of BSA were added with a 
Hamilton syringe. Refluxing for 24 h until solution became clear. After cooling to r.t. 3.22 g 
(6.1mmol) activated quinine ester hydrochloride 5 were added and stirred for additional 24 h. 
The reaction was quenched with MeOH. After a few minutes a viscous gum was formed 
which was removed, redissolved in MeOH and combined with the reaction solution. 
Purification by chromatography (dichloromethane : methanol 10:1 – 1:1) yielded 2.10 g      
(92 %) of yellowish crystals.  
1H-NMR [CD3OD]: δ = 1.7 (m, 1H), 1.79-1.98 (m, 1H), 2.08 (m, 1H), 2.22 (m, 2H), 2.78 (m, 
1H), 3.18-3.28 (m, 1H), 3.35-3.51 (m, 2H), 3.66 (m, 1H), 3.83 (t, 1H), 4.01 (s, 3H), 4.58-4.72 
(m, 1H), 4.99-5.14 (m, 2H), 5.74 (m, 1H), 7.04 (s, 1H), 7.45-7.57 (m, 2H), 7.83 (m, 1H), 
8.00(m, 1H), 8.78 (m, 1H). 
MS (ESI, positive): 520.3 [M+H]+. 
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6 List of Abbreviations  
 
 ///   no value  
 AIBN   azo-bisisobutyronitril  
 AX   anion exchange  
 BSA   N,O-bistrimethylsilylacetamide  
 CSA   cysteic acid 
 CSAD   cysteic acid derivative 
 CSP   chiral stationary phase  
 CX   cation exchange  
 DACH   diaminocyclohexane  
 DCC   N,N'-dicyclohexylcarbodiimide  
 DH-QD  dihydroquinidine 
 DH-QN  dihydroquinine 
 DMF   N,N-dimethylformamide 
 DMSO  dimethyl sulfoxide  
 e.g.   exempli gratia, for example 
 ESI-MS  electrospray ionization mass spectrometer 
 et al..   et alii, and others 
 etc.   et cetera, and so on  
 h   hours  
 HOAc   acetic acid 
 HPLC   high performance liquid chromatography 
 LC   liquid chromatography 
 LC-MS  liquid chromatography-mass spectrometry 
 MeI   methyliodide 
 MeOH   methanol 
 MP   mobile phase 
 n.d.   not determined 
 NMR   nuclear magnetic resonance  
 QD   quinidine 
 QN   quinine 
 QD-AX  quinidine anion exchanger 
 QN-AX  quinine anion exchanger 
 84
 RP-HPLC  reversed phase - high performance liquid chromatography 
 r.t.   room temperature 
 SA   selectand 
 SAX   strong anion exchange 
 SO   selector  
 TLC   thin layer chromatography 
 WAX   weak anion exchanger 
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Summary  
 
Recent studies in our group established the concept of zwitterionic cinchona-alkaloid based 
chiral stationary phases (ZWIX-CSPs) by fusing anion- and cation exchanger selectors into 
single ZWIX-selector molecules. In the course of further exploration of such ZWIX-type 
CSPs the main focus of the presented thesis was therefore the synthesis and the 
chromatographic evaluation of newly designed zwitterionic ion exchange-type CSPs. 
The diploma work was based on the Taurine-Quinine (Tau-QN) selector motif and starting 
from there, the synthetic efforts focused on one hand on O9-carbamate modifications to 
introduce further ion exchange functionalities, and on the other hand on variations of the 
cinchona scaffold.  
 
In particular, with Tau-QD (CSP 1) the pseudoenantiomeric CSP to Tau-QN was prepared. 
Furthermore, the introduction of a cysteic acid functionality to the well established quinine 
based anion exchanger (QN-AX) led to L-CSA-QN (CSP 2), which provided both a weak and 
a strong cation exchanger (WCX, SCX) site. By quaternizing the initially weak anion 
exchanger site (WAX) of the cinchona scaffold a strong anion exchanger (SAX) resulted in 
Tau-N-Methyl-QN (CSP 4). With Tau-Quinc (CSP 5), which employed quincorine instead of 
quinine as alkaloid scaffold, the importance of the aromatic quinoline group in the SO could 
be assessed. With preparation of L-CSAD-DH-QN (CSP 6) an alternative site for covalent 
immobilization to the silica support – via the cation exchanger part instead of the anion 
exchanger alkaloid – was tested. Apart from these zwitterionic CSPs, a bisbasic selector was 
synthesized via introduction of a quinuclidine moiety into the QN-AX motif  (Quinu-QD, 
CSP 3).  
 
The prepared chiral stationary phases were subject to investigation by HPLC. Enantiomer 
separation performance as well as general chromatographic key parameters like retention, 
resolution and selectivity, were monitored for a diverse set of chiral acids, bases and amino 
acids while no mobile phase optimizations were carried out due to time limitations.  
 
Comparison of pseudoenantiomeric CSPs Tau-QN and –QD essentially showed that switch of 
elution order of amino acid analytes could be effected - thereby indicating the guiding 
influence of the alkaloid scaffold.  
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The quaternized anion exchanger group in CSP 4 is also functional in zwitterion exchange, 
whereas the site of SO immobilization has not shown major impact on CSP performance. The 
quinoline moiety in the SO was found to be fundamental for enantiomer separation as with 
Tau-Quinc (CSP 5) only two analytes could be partially resolved.  
Generally, structural modifications on the selectors` zwitterionic scaffolds and interpretation 
of the obtained chromatographic data helped to enlarge the understanding of the complex 
molecular recognition process.  
 
To summarize, synthesis of novel ZWIX-selectors was carried out and optimized, which led 
to the preparation of six novel CSPs followed by their chromatographic evaluation. The CSPs 
show high chemical and mechanical stability, the degree of flexibility in terms of synthetic 
pathways following a combinatorial concept in combination with the potential of mobile 
phase optimization will open up an area to establish ZWIX-CSPs as a powerful addition to the 
pool of already established CSPs on the market.  
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Zusammenfassung 
 
Die vorliegende Arbeit handelt von der Herstellung und chromatographischen Evaluierung 
zwitterionischer chiraler stationärer Phasen (CSPs). Basierend auf vorangegangenen Arbeiten 
unserer Gruppe wurden Säurefunktionalitäten in einen (bereits etablierten) Chinin-basierten 
Anionenaustauscher (QN-AX) eingeführt und somit das Konzept eines zwitterionischen 
Selektors (SO) realisiert. Durch Immobilisierung des Selektors auf modifiziertem Kieselgel 
wurden neuartige chirale stationäre Zwitterionenaustauscher-Phasen (ZWIX-CSPs) 
geschaffen, welche Enantiomerentrennung von chiralen Säuren, Basen und amphoteren 
Verbindungen ermöglichen.  
 
Insgesamt konnten fünf verschiedene zwitterionische chirale Austauscherphasen hergestellt 
werden. Es wurden Sulfon- und Carbonsäuregruppen an der O9-Carbamat Position von 
Cinchona-Alkaloiden (vorrangig Chinin und sein Pseudoenantiomer Chinidin) eingeführt und 
dadurch Selektoren mit starken und schwachen Ionenaustausch-Mechanismen geschaffen. 
Durch strukturelle Modifikationen an den Alkaloidgerüsten, wie z.B. Methylierung der 1-N 
Position an Chinin oder die Einführung einer neuen Selektor-Bindungsstelle an das Kieselgel, 
wurde das Spektrum der Interaktionsmöglichkeiten zwischen Selektoren und Analyten 
erweitert. Es wurde auch ein Selektor auf Basis des Chincorins synthetisiert, welcher durch 
einen fehlenden Chinolin-Rest gekennzeichnet ist. Zusätzlich zu den zwitterionischen Phasen 
wurde durch Fusion eines Chinuclidin-Motivs mit einem Chinidin-basierten 
Anionenaustauscher eine bisbasische CSP hergestellt.  
 
Als Ergänzung zur synthetischen Arbeit erfolgte eine Evaluierung der CSPs auf einem HPLC-
System. An Hand eines breit angelegten Sets an chiralen Säuren,  Basen und freien 
Aminosäuren wurden die Phasen sowohl auf ihre chirale Trennleistung als auch auf 
allgemeine chromatographische Parameter hin untersucht.  
Mit den ZWIX-CSPs konnte auch unter nicht-optimierten Elutionsbedingungen 
Basislinientrennung für alle drei Analytklassen erzielt werden. Außerdem konnte gezeigt 
werden, dass das pseudoenantiomere Verhalten von Chinin und Chinidin in den ZWIX-
Selektoren erhalten bleibt, was sich durch eine Umkehr der Elutionsreihenfolge der 
getrennten Enantiomere widerspiegelt. Jedoch führten weder die Veränderung der 
Selektorbindungsstelle an das Kieselgel noch die Einführung einer bisaciden Seitenkette zu 
einer Verbesserung der Trennleistung.  
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Weiters können aromatische Reste in den ZWIX-Selektoren als essentielle Bestandteile für 
Enantioselektivität angesehen werden, da auf dem Chincorin-basierten SO keine 
Basislinientrennung erzielt werden konnte.  
 
Zusammenfassend kann angemerkt werden, dass neue Synthesekonzepte erstellt und 
Synthesen für zwitterionische Selektoren durchgeführt und optimiert wurden. Die durch 
Immobilisierung auf modifiziertem Kieselgel realisierten CSPs lieferten großteils 
vielversprechende Trennleistungen. Das breite Anwendungsspektrum auf saure, basische und 
amphotere Verbindungen, die hohe mechanische und chemische Stabilität, sowie die milden 
Elutionsbedingungen zeigen das große Potential dieser zwitterionischen chiralen stationären 
Phasen. 
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